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ABSTRACT
Acoustic cavitation (i.e. acoustically stimulated microbubble activity) has gained
interest in the biomedical community due to its ability to locally concentrate me-
chanical forces inside the body. Biological structures in close proximity experience
stresses that temporally disrupt their normal function and allow passage of material
that would otherwise be impermeable. Examples include blood-brain barrier dis-
ruption, enhanced penetration of drugs into tumors, disruption of the blood vessel
endothelium, and permeabilization of cell membranes (i.e. sonoporation).
The goal of this thesis was to investigate a new class of acoustic cavitation nuclei
for sonoporation called phase-shift nanoemulsions (PSNE). Ultrasound can be used
to nucleate, or phase-shift PSNE into microbubbles with a process termed acoustic
droplet vaporization (ADV). Specifically, the focus was to use PSNE for delivery of
small interfering RNA (siRNA) to an in vitro cell suspension using sonoporation.
Small interfering RNA is an exogenous RNA molecule and has gained increased at-
tention due to its ability to knockdown specific proteins central to disease progression.
Results showed that siRNA delivery with PSNE is possible with high uptake effi-
ciency (i.e. ratio of the number of cells with uptake to the number of cells originally).
v
Uptake was highly dependent on the amount of acoustic cavitation activity gener-
ated from PSNE. The acoustic emissions from individual PSNE were explored to
understand the microbubble dynamics following ADV. Results showed that PSNE
immediately undergo an explosive growth and collapse at the ADV threshold, and
the maximum size of the microbubble depends on the ultrasound frequency. This
led to the hypothesis that the sonoporation efficiency with PSNE is governed by the
choice of frequency. Lower frequencies were shown to expand microbubbles to larger
maximum radii, which in turn caused more energetic collapses leading to cell death.
This explains the lower uptake efficiencies at lower frequencies (39.45% at 1 MHz
and 46.62% at 2.5 MHz), compared to the relatively high uptake efficiency at 5 MHz
(66.81%).
In general, uptake efficiencies >50% have rarely been achieved with current sono-
poration methods and these results are a significant improvement. PSNE could also
serve as a unique platform for numerous other therapeutic ultrasound applications
that utilize the mechanical effects of acoustic cavitation. The frequency-dependent
control over the microbubble dynamics following ADV could provide a way to tune
the level of stress experienced by biological structures.
vi
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1Chapter 1
Introduction
1.1 Therapeutic Ultrasound
Biomedical acoustics is developing rapidly, largely in part to the innovations and tech-
nological advances within the field of therapeutic ultrasound. Transcranial ultrasound
arrays have been developed for delivery of focused ultrasound (FUS) energy into the
brain. Under the guidance of magnetic resonance imaging, numerous preclinical and
pilot trials are underway utilizing this technology for treatment of numerous diseases
(Coluccia et al., 2014; Dobrakowski et al., 2014). While these applications employ
high amounts of ultrasound energy to ablate or destroy brain tissue, more subtle ap-
proaches using FUS-stimulated microbubble activity has been shown to temporarily
open the blood-brain barrier, increase vascular permeability, enhance drug penetra-
tion into tumors, and temporarily disrupt cell membranes (Konofagou, 2012; Chen
and Hwang, 2013; Liang et al., 2010). In combination with these techniques, novel
microbubble-based drug delivery vehicles have been developed for enhancing gene
and drug delivery to areas in the body using FUS-stimulated microbubble activity
(Kooiman et al., 2014). These examples highlight a few of the exciting applications
of therapeutic ultrasound, which all rely on the ability of ultrasound to directly or
indirectly interact with biological tissue.
Traditionally, ultrasound is mainly viewed as a diagnostic tool to image inside the
body. Ultrasound waves are transmitted into the body where they are scattered and
reflected by inhomogeneities and boundaries. The return echoes are then processed
2to provide a spatial map of echo intensity, corresponding to the locations of inhomo-
geneities and boundaries. This is made possible because ultrasound can interact with
tissue, mainly where there are changes in density and sound speed. The ability to
treat human disease with ultrasound also lies in its ability to interact with biological
tissue and structures. FUS beams can be used to deposit high amounts of ultrasound
energy into tissue, where absorption can lead to tissue heating. This can be used
to non-invasively destroy tissue inside the body, such as solid tumors or overactive
regions in the brain. In a different form of tissue ablation, circulating microbubbles
in the bloodstream can be activated with ultrasound to cause significant mechanical
damage leading to tissue death. In this case, the microbubbles are doing mechanical
work to destroy tissue and ultrasound is indirectly responsible. Additionally, mi-
crobubbles can be activated in more subtle ways to produce temporary effects, such
as pemeabilzatin of biological structures. The mechanisms of therapeutic ultrasound
can be categorized as thermal or mechanical.
Thermal effects are usually created using long pulses (>ms) of high intensity ul-
trasound to allow for significant absorption of ultrasound energy, primarily due to
viscous absorption. Mechanical effects can be produced using long or short (few µs)
pulses of low, moderate, or high intensity ultrasound and the most common cause is
ultrasound-stimulated microbubble activity. This thesis will focus on the mechanical
effects caused by microbubble activity. The subsequent sections will provide back-
ground related to how microbubble activity is created in the body and utilized for
therapeutic ultrasound applications. The remainder of this thesis will investigate a
new type of particle to generate microbubble activity, called a phase-shift nanoemul-
sion (PSNE). Detailed experiments were carried out to understand the microbubble
properties of PSNE and how they can be used to permeabilize cell membranes for
intracellular macromolecule delivery using FUS and microbubbles.
31.2 Acoustic Cavitation
As put simply by Dr. Robert Apfel, acoustic cavitation is defined as acoustically
stimulated bubble activity (Apfel, 1997). This is a subset of cavitation, where stimu-
lation can also occur from heat, flow, decompression, and deposit of electromagnetic
or ionizing energy. The varying pressure of an acoustic wave can act to create or
stimulate bubbles in a liquid. When dealing with cavitation inception or creation,
the tensile strength of the liquid is a crucial factor. The varying pressure of an acous-
tic wave can put a liquid into tension when the negative pressure amplitude falls
below the ambient pressure. If sufficient tension is applied, the fluid can rupture and
create a cavity that will fill with liquid vapor and dissolved gas. Inhomogeneities and
contaminants present in the liquid can lower the tensile strength from that which is
predicted with theory. When rupture occurs at these sites it is termed heterogeneous
nucleation. Homogeneous nucleation refers to thermal motion of liquids that form
tiny, microscopic voids that can rupture and grow under the tension of an acoustic
wave (Brennen, 2014).
In regards to therapeutic ultrasound, stabilized gas bodies are not typically present
inside the body and therefore artificial cavitation nuclei (i.e stabilized microbubbles)
are introduced into the body (described in detail in the following section). In this
case, the bubbles are already present and ultrasound can be used to stimulate the
bubbles into motion. The motion can be gentle or violent depending on numerous
parameters, most notably the size of the bubble, ultrasound frequency, and the ultra-
sound pressure. Stable cavitation refers to linear and nonlinear volumetric pulsations
around some equilibrium size. Inertial (transient) cavitation is defined as a rapid ex-
pansion and collapse of a bubble, where the bubble grows to double, and often many
times its original size. Figure 1·1 summarizes the two types of acoustic cavitation
and their response to a ultrasound pulse.
4Clearly it is important to define the threshold where transition from stable to in-
ertial cavitation occurs. Holland and Apfel (1989) developed an analytical formula in
an attempt to predict the probability of inertial cavitation from diagnostic ultrasound
(Holland and Apfel, 1989; Apfel, 1986). It is important to first start with the Blake
threshold (Blake, 1949). This model mainly applies to very small bubbles, where
overpressure from surface tension dominates, and predicts the stability of a bubble in
response to a quasi-static pressure change in the liquid. If sufficient tension is applied
in the liquid to overcome the confining surface tension pressure, the bubble grows
and reaches a critical radius where the pressure balance across the bubble wall can-
not be maintained. The bubble is therefore unstable and and undergoes an explosive
growth. Since the tension cannot be maintained indefinitely, the bubble will expand
to a maximum radius and collapse. As emphasized by Leighton (1994), this model
ignores inertial and viscous effects of the liquid and therefore cannot fully describe
the explosive growth, but it can be a good predictor for the onset of explosive growth,
where surface tension dominates.
Holland and Apfel (1989) expanded upon the Blake threshold and developed a
formula to predict the ultrasound pressure threshold that will cause inertial cavita-
tion. They included inertial, viscous, and surface tension effects in their derivation
which expanded its application. They looked at the response of a bubble to a single
ultrasound cycle and tried to determine whether the bubble can grow sufficiently in
the allotted time given by the ultrasound period. By deriving inertial, viscous, and
surface tension time delays associated with the bubble start-up, they defined three
criteria for inertial cavitation to occur: (1) the acoustic pressure must be greater
than the Blake threshold pressure (2) the time delays associated with the bubble
start must be less than the acoustic period and (3) the bubble must collapse ener-
getically. They defined energetically as enough to cause the gas inside the bubble to
5be heated to at least 5000 K upon collapse. This formulation yielded the mechanical
index, which predicts the likelihood of inertial cavitation from the short pulses of
ultrasound (Apfel and Holland, 1991). It is important to limit the above formulation
to this scenario. One advantage of the formulation is that key parameters and rela-
tionships are identified. A main take away from their derivation is that the required
peak negative pressure for inertial cavitation increases with decreasing bubble sizes
due to surface tension effects, while it increases with increasing bubble size due to
inertial and viscous effects. Lastly, for fixed bubble sizes, lower frequencies allow more
time for bubble growth during rarefactional periods and therefore have been utilized
in therapeutic ultrasound applications to create inertial cavitation. These concepts
are important and will be utilized in subsequent chapters to describe the behavior of
PSNE in an acoustic field.
1.2.1 Artificial Cavitation Nuclei
Microbubbles have large scattering cross-sections in the diagnostic ultrasound fre-
quency range (1-10 MHz) that make them ideal candidates as ultrasound contrast
agents (UCAs). Numerous formulations of UCAs have been developed for injection
into the bloodstream to enhance ultrasound image brightness and contrast. The in-
herent nonlinear properties of UCAs have also led to the development of microbubble
specific imaging techniques. Naturally, researchers have transitioned UCAs from di-
agnostic to therapeutic ultrasound applications where they serve as excellent acoustic
cavitation nuclei (Ferrara et al., 2007).
Low diffusivity gases and stabilizing lipid, polymer, and protein shells have been
used for UCA fabrication to prolong their persistence in circulation. However, UCAs
are limited to the vascular system due to their size (1-10 µm) and are quickly cleared
from circulation within minutes of injection by the mononuclear phagocyte system and
dissolution (Unger et al., 2004; Garg et al., 2013). Therefore, researchers have begun
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Figure 1·1: Illustration of the different types of acoustic cavitation.
to explore numerous other types of acoustic cavitation nuclei. They can be separated
into two categories: 1) bubble or 2) non-bubble based nuclei (Deshpande et al., 2010).
Bubble based nuclei include the aforementioned UCAs along with echogenic liposomes
and nanobubbles (Buchanan et al., 2008; Wang et al., 2010; Perera et al., 2015).
Non-microbubble based nuclei mainly consist of nanoparticle based formulations such
as PSNE and solid nanoparticles (Liu et al., 2006; Kwan et al., 2015). Micron-
sized perfluorocarbon (PFC) droplets are also included in this category, which will
be discussed in Section 2.2.1 (Kripfgans et al., 2000). Liquid and solid nuclei require
ultrasound activation to create microbubbles. PSNE are initially liquid and must
7be converted into microbubbles using ultrasound. PSNE will be described in more
detail in Section 2.2.3. Kwan et al. (2015b) have developed polymeric nanoparticles
called nanocups, which can trap gas and serve as a heterogeneous nucleation nuclei
for creation of inertial cavitation in the body.
1.2.2 Bioeffects
A beneficial or detrimental aspect of acoustic cavitation, depending on the applica-
tion, is its ability to concentrate energy. Ultrasound waves perturb tissue on a bulk
scale, since their wavelengths (v1.5 mm at 1 MHz) are much larger than the size of
cells. Acoustic cavitation takes energy from that ultrasound wave and focuses it down
to the cellular scale. Both stable and inertial cavitation have been shown to create
stresses due to rapid expansion/collapse, build up of high temperatures and pressures
on collapse, microstreaming, shockwave emission, and microjetting (Neppiras, 1980;
Leighton, 1994; Coussios and Roy, 2008). Biological structures in close proximity ex-
perience stresses that temporally disrupt their normal function and allow passage of
material that would otherwise be impermeable. Examples include blood-brain barrier
disruption, enhanced penetration of drugs into tumors, disruption of the blood vessel
endothelium, and permeabilization of cell membranes (i.e. sonoporation) (Konofagou,
2012; Chen and Hwang, 2013; Liang et al., 2010).
1.3 Nanomedicine
The application of nanotechnology to medicine has immense potential to address nu-
merous deficiencies on how we detect and treat disease (Farokhzad and Langer, 2006).
Engineering unique nanoparticles for drug delivery applications can help address con-
cerns with toxicity, drug release, targeting, and stability. For example, chemothera-
peutics can be packaged into nanoparticles to reduce systemic toxicity and increase
the effective dose delivered to tumors (Ferrari, 2005). Numerous other multifunc-
8tional nanoparticles have been engineered for applications in medicine (Zhang et al.,
2008).
Figure 1·2 highlights how the physiochemical properties of nanoparticles (size, zeta
potential, and solubility) effect their pharmacokinetics and biocompatibility. With
the right properties, nanoparticles can take advantage of the enhanced permeability
and retention (EPR) effect. This is a property of tumors and inflamed tissue, where
nanoparticles within a certain size range can extravasate and accumulate in tissue
due to abnormal blood vessel architecture and impaired lymphatic drainage (Maeda,
2010; Bae and Park, 2011). Numerous researchers have looked at combining the
benefits of nanoparticles with the potential benefits of acoustic cavitation.
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Figure 1·2: Graphical representation of how nanoparticle properties
effect their pharmacokinetics and biocompatibility. Adapted from Mc-
Neil (2009).
1.3.1 RNA Interference Therapeutics
Therapeutics based on RNA interference (RNAi) are in development for numerous
diseases including cancer, viral infections, and other genetic disorders (Davidson and
McCray, 2011). These double stranded RNA molecules allow post-transcriptional
modification of gene expression with remarkable potency and specificity (Vaishnaw
9et al., 2010). In particular, small interfering RNAs (siRNA) have attracted much
interest for their ability to knockdown specific proteins central to disease progression
(Lares et al., 2010). Once introduced into the cytosol of cells, siRNA molecules are
incorporated into the RNAi pathway where they lead to degradation of complemen-
tary messenger RNA molecules, which in turn leads to a reduction in targeted protein
expression (Elbashir et al., 2001). In theory, this opens up the possibility of targeting
any of the approximately 20,000 genes in the human genome with synthetic siRNA
molecules. Proteins once considered undruggable using conventional small molecules
can now be targeted, which could have a profound impact on the treatment of human
diseases (Wu et al., 2014).
Effective siRNA delivery has remained an elusive challenge in the pursuit of its use
as a systemically administered therapeutic. The combined effect of nanoparticles and
acoustic cavitation could address some of the issues. Small interfering RNA are large
(v14 kDa), highly anionic, susceptible to enzymatic degradation, and rapidly filtered
from circulation by the kidneys (Tokatlian and Segura, 2010). Progress has been made
in improving the pharmacokinetic properties of siRNA therapeutics through chemical
modifications to the siRNA molecule and packaging into nanoparticles (Zhang et al.,
2007; Behlke, 2008; Whitehead et al., 2009). Numerous lipid and polymer based
nanoparticles are currently being developed for siRNA delivery with a few under clin-
ical trials (Burnett et al., 2011). These nanoparticles extend the half-life of siRNA in
circulation and protect against degradation en route to diseased tissue. In regards to
cancer therapies, nanoparticles are able to accumulate in tumors through the EPR
effect (Fang et al., 2011). Nanoparticles are then internalized by cells through endo-
somal pathways, where endosomal escape must occur in order to release siRNA into
the cytosol where it can access RNAi machinery.
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1.4 Motivation & Scope
The motivation of this thesis was to utilize the acoustic cavitation properties of PSNE
for applications within nanomedicine. Combining the beneficial bioeffects of acoustic
cavitation, with the unique properties of nanoparticles, has a synergistic effect that
could enable innovative approaches to the treatment of disease. Specifically, the scope
of the thesis was to investigate the potential of using PSNE for siRNA delivery to a
cell suspension with sonoporation. This was done through a series of proof of concept
in-vitro experiments that lay the foundation for future experiments.
1.4.1 Dissertation Structure
The structure of this dissertation is written to walk the reader from the basics of
PSNE, their cavitation properties, how these properties relate to sonoporation, and
end with delivery of siRNA. This is different from how experiments were carried out.
The first question asked was: can PSNE be used to deliver siRNA to a suspension of
cells using sonoporation? Initial experiments focused on testing this hypothesis and
showed that siRNA delivery with PSNE was feasible and more efficient than what
had been published. This brought about a new question: Why is sonoporation with
PSNE so efficient (i.e. minimal cell death and high uptake of siRNA)? This led to
an investigation of the acoustic cavitation properties of PSNE and the final question:
can control over the sonoporation efficiency be achieved with the frequency-dependent
acoustic cavitation properties of PSNE? Experiments were carried out as follows:
1. siRNA delivery with PSNE (Chapter 4)
2. Acoustic cavitation properties of PSNE (Chapter 2)
3. Frequency-dependent sonoporation efficiency (Chapter 3)
11
This thesis is written in reverse order. The structure was selected to provide
the reader with background related PSNE properties and builds up to their use for
delivery of siRNA using sonoporation. Therefore, individual chapters build upon the
previous so that experimental findings and conclusions can be carried on throughout
the thesis.
12
Chapter 2
Phase-shift Nanoemulsions
2.1 Scope
This chapter focuses on the use of PSNE as acoustic cavitation nuclei. Background
will be provided in regards to perfluorocarbon droplets and acoustic droplet vaporiza-
tion (ADV). The rest of the chapter will detail how PSNE are fabricated, character-
ized, and acoustically activated. Specifically, how the choice of ultrasound frequency
affects the dynamics of microbubbles derived from PSNE after ADV. An experimen-
tal investigation was carried out to capture acoustic emissions from individual PSNE
after ADV at multiple frequencies (1, 2.5, and 5 MHz) and was compared with the-
oretical predictions using the Rayleigh collapse model. Results highlight that the
maximum radius (Rmax) of the microbubble can be controlled with the choice of ul-
trasound frequency, thus providing a way to tune the microbubble dynamics following
ADV of PSNE for specific therapeutic ultrasound applications.
2.2 Background
2.2.1 Perfluorocarbon Droplets
As stated in Section 1.2.1, engineering artificial cavitation nuclei for acoustic cavita-
tion generation inside the body is a major research interest within the field of ther-
apeutic ultrasound. PFC droplets have emerged as a unique alternative to gas-filled
UCAs for numerous therapeutic and diagnostic ultrasound applications (Kripfgans
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et al., 2000; Sheeran and Dayton, 2012). These liquid drops consist of a perfluo-
rocarbon with a boiling point that is lower than physiological temperature (37 ◦C)
and therefore exist in a superheated, metastable state. The phase change from liq-
uid to vapor can be initiated with ultrasound in a process termed acoustic droplet
vaporization (Apfel, 1998).
PFC droplets are coated with biocompatible surfactants, such as lipids, polymers,
and/or proteins that provide stability during production and a biocompatible surface
for injection into the body. Their ability to remain in a liquid state at superheated
temperatures is due to their existence as droplets. It is well known that heterogeneous
nucleation of vapor bubbles can be suppressed by suspending droplets of a volatile
liquid, in a nonvolatile liquid in which it has low solubility (Apfel, 1971; Avedisian,
1985; Shepherd and Sturtevant, 1982). PFCs are characterized as being extremely
hydrophobic with low solubility in water, therefore PFC in water droplets are ideal
candidates for this scenario (Riess, 2001). Since there are no motes or crevices along
the interface of the two fluids, the nucleation process is inhibited until sufficient
heating and/or pressure decrease has occurred to trigger homogeneous nucleation
within the droplet core. An added effect for small droplets is the increased pressure in
the droplet core due to surface tension at the PFC-water interface, which can further
inhibit the nucleation process. Using the Antoine vapor-pressure relation, researchers
have shown that the pressure due to interfacial surface tension (Laplace over pressure)
can elevate the vaporization temperature of submicron lipid coated PFC droplets by
30 - 60 ◦C depending on their size (Rapoport et al., 2009a; Sheeran et al., 2011).
The inhibition of heterogeneous nucleation and increased internal pressure acts to
shift the boiling point of the perfluorocarbon to the spinodal curve, where researchers
have shown that submicron PFC droplets can exist up to approximately 90% of their
critical temperature (Mountford et al., 2015b; Mountford et al., 2015a).
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Typical perfluorocarbons used for PFC droplet fabrication are shown in Table
2.1. Perfluoropentane is most widely used since it is liquid at room temperature
and therefore easier to handle than more volatile perfluorocarbons. Initial fabrication
techniques utilized high speed shaking and probe tip sonicators, where a small volume
percentage (v10%) of perfluoropentane is emulsified into an aqueous phase containing
a stabilizing surfactant (Kripfgans et al., 2000). Typically, these processes are done
in ice baths to prevent heating and vaporization of the perfluorocarbon and generally
yield micron-sized perfluorocarbon droplets. Fabiilli et al. (2010) has also shown
proof of concept fabrication techniques that utilize the PFC core as a drug reservoir.
A double emulsion technique was used to suspend therapeutic payloads as nested
droplets inside the PFC, thus forming water-in-PFC-in-water or oil-in-PFC-in-water
emulsions (Fabiilli et al., 2010b; Fabiilli et al., 2010a).
Additional energy is required at the emulsification step or supplementary tech-
niques are necessary to produce submicron perfluorocarbon droplets. Kopechek
(2012) demonstrated the use of a high pressure extrusion technique after emulsifica-
tion to reduce the PFC droplet size and polydispersity. Depending on the filter used
during extrusion, mean PFC droplet sizes can range from 100 - 300 nm. Recently,
novel microbubble condensation techniques have emerged as a method to produce
submicron droplets with more volatile perfluorocarbons that cannot be fabricated
with traditional shaking and sonication techniques (Sheeran et al., 2011; Sheeran
et al., 2012). This technique uses perfluorocarbons that are gaseous at room temper-
ature and starts with making perfluorocarbon microbubbles using high speed shaking
or ultrasonic sonication. The microbubbles are then cooled and pressurized to pro-
mote condensation of the gas microbubbles to submicron liquid droplets. Sheeran
et al. (2012) showed that both perfluorobutane and perfluoropropane lipid coated
microbubbles are able to produce stable, submicron droplets with this technique. Mi-
15
Name Molecular Weight Boiling Point Critical
Temperature
Perfluoropropane (C3F8) 188 g/mol −38 ◦C 72 ◦C
Perfluorobutane (C4F10) 238 g/mol −2 ◦C 113 ◦C
Perfluoropentane (C5F12) 288 g/mol 29
◦C 149 ◦C
Perfluorohexane (C6F12) 338 g/mol 59
◦C 177 ◦C
Table 2.1: Perfluorocarbons used in droplet fabrication.
crobubbles with mean diameters of v1 µm formed submicron droplets with mean
diameters of 200 - 400 nm upon condensation of the PFC gas core.
2.2.2 Acoustic Droplet Vaporization
As metastable droplets, small increases in temperature and/or small decreases in
pressure within the PFC core can initiate the vaporization process. Kripfgans et al.
(2000) was the first to experimentally demonstrate the ADV of PFC droplets using
ultrasound and yielded interesting results in regards to the physics of the ADV pro-
cess. A range of frequencies (1.5 to 8 MHz) were used for vaporizing droplets and
the pressure threshold for vaporization decreased with increasing frequency. This is
contradictory to the frequency dependence for acoustic cavitation, where lower fre-
quencies promote a higher probability of cavitation inception as described in Section
1.2. Numerous researchers have confirmed and contradicted these initial findings
in regards to the frequency dependence (Kripfgans et al., 2002; Schad and Hyny-
nen, 2010; Martin et al., 2012; Sheeran et al., 2013a; Williams et al., 2013; Shpak
et al., 2014). Williams et al. (2013) confirmed these findings, showing that the ADV
threshold for submicron droplets decreased with increasing frequencies at 5, 10, and
15 MHz. Sheeran et al. (2013) showed the opposite, that the threshold increases with
increasing frequency and is consistent with results by Martin et al. (2012). However,
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it is generally accepted within the biomedical ultrasound community that the ADV
threshold for PFC droplets decreases with frequency and droplet size. The boiling
point of the PFC and degree of superheat have also been shown to influence the ADV
pressure threshold, with decreasing pressures needed at higher degrees of superheat
(Zhang and Porter, 2010; Fabiilli et al., 2009). Fabiilli et al. (2010) investigated the
relationship between ADV and the inertial cavitation threshold by studying fluid pa-
rameters that influence the inertial cavitation threshold. They showed that ADV of
micron sized PFC droplets occurred at lower peak negative pressures than the inertial
cavitation threshold. From these results, they concluded that inertial cavitation is not
necessary to cause ADV and cavitation occurs inside the droplet core, not external.
The frequency dependence behind the ADV of PFC droplets had baffled scientists
until high-speed imaging experiments were performed to capture the initial stages of
ADV (Wong et al., 2011; Reznik et al., 2011; Shpak et al., 2013a; Li et al., 2014).
Shpak et al. (2013a) imaged the ADV of micron sized PFC droplets at frame rates
up to 20 Mfps. Their results described three regimes during the ADV process: (1)
oscillatory translations of the droplet prior to nucleation; (2) rapid growth of the vapor
bubble due to ultrasound-driven rectified heat transfer; and (3) a gradual expansion of
the vapor bubble after the ultrasound stops. They used a simple model to demonstrate
that the process is controlled by heat transfer, with an increased growth while the
ultrasound is on due to ultrasound-driven rectified heat transfer. The role of gas
in ultrasound-driven vapor growth was also explored by Sphak et al. (2013b) using
high-speed imaging and theoretical predictions. They stressed the importance of gas
diffusion in order to prevent the recondensation of the vapor bubble during collapse.
Sphak et al. (2014) followed up these results with another study showing that
ADV is initiated by superharmonic focusing of ultrasound by the droplet. Due to
nonlinear sound propagation, the ultrasound wave arrives at the droplet with higher
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order harmonic frequencies present in the wave. These superharmonics contribute
to a focusing effect inside the droplet that leads to an amplification of the pressure
decrease inside the droplet. Using high speed imaging experiments along with theo-
retical predictions, Sphak et al. (2014) were able to find excellent agreement with the
proposed reasoning. These predictions also showed that the pressure is amplified with
increasing frequency and can begin to explain the frequency dependence of ADV as
seen in Kripfgans et al. (2000). While their theory correlated well with micron sized
PFC droplets, it is unknown how this study will translate to smaller nanodroplets
and if the same superharmonic focusing phenomenon will be seen.
Submicron PFC droplets have shown conflicting results compared to their mi-
cron sized counterparts during high speed imaging experiments (Reznik et al., 2011;
Reznik et al., 2013). Unlike the gradual expansion of micron sized droplets after va-
porization, the microbubbles from submicron droplets were observed to rapidly grow
to a maximum size (up to 10 µm in diameter) and collapse (Reznik et al., 2013). This
occurred after the passage of the ultrasound pulse and therefore was considered as
an unforced bubble collapse, controlled by the inertia of the surrounding fluid. An
example image from this study showed a single submicron droplet undergoing ADV
and highlighted this transient nature, where the bubble is seen to rapidly expand,
collapse, and rebound after passage of the ultrasound wave. While this was of inter-
est to Reznik et al. (2013), their main goal was to study the stability of microbubbles
following ADV of submicron droplets. They described numerous other fates after
ADV, such as collapse, coalescence, steady oscillations, dissolution, and survival.
In summary, an incident ultrasound wave arriving at a PFC droplet will be scat-
tered. This creates a scattered wave and a refracted wave that propagates into the
droplet. Sphak et al. (2014) et al. showed that superharmonics in the propagating
wave can be focused or amplified in the refracted wave and the effect increases with
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increasing frequency. In any case, a point of sufficient low pressure is created inside
the droplet that leads to homogeneous nucleation of the droplet core. This occurs
during the peak negative cycle of the ultrasound wave, slightly shifted to the end
of the peak negative half cycle (Shpak et al., 2014). At this point, depending upon
the droplet’s size, the newly formed vapor bubble expands due to heat transfer to
an equilibrium bubble size. Micron sized PFC droplets have shown a gradual growth
and possible overshoot of their equilibrium radius that causes free bubble oscillations
(Sheeran et al., 2014). Submicron PFC droplets seem to grow significantly beyond
R0 and reach high enough expansion ratios (Rmax/R0) to cause inertial collapse. The
ensuing sections will explore the dynamics of submicron PFC droplets, with an aim
to understand their transient growth and collapse after ADV.
2.2.3 Phase-shift Nanoemulsions
Phase-shift nanoemulsions (PSNE) are submicron PFC droplets. Figure 2·1 shows a
cartoon representation of a PSNE coated with phospholipids. After an initial emul-
sification step, high pressure extrusion is used to reduce the mean size to 100-300
nm. PSNE were first conceived as a nucleation agent for bubble-enhanced heating
during high intensity focused ultrasound ablation (Zhang and Porter, 2010; Farny
et al., 2010). Since then, studies have shown that PSNE are able to accumulate in
intramuscular tumors in vivo and accelerate the heating rate of ultrasound ablation
(Kopechek et al., 2013; Kopechek et al., 2014). PSNE have been used for numerous
other biomedical applications including drug delivery (Rapoport et al., 2011; Wang
et al., 2012; Javadi et al., 2012), contrast-enhanced ultrasound imaging (Williams
et al., 2013; Sheeran et al., 2013b), and blood-brain barrier disruption (Chen et al.,
2013). The following sections will detail how PSNE are fabricated and acoustically
characterized, with an emphasis of the frequency-dependence of the microbubble dy-
namics following ADV.
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Figure 2·1: Cartoon representation of a phase-shift nanoemulsion.
2.3 Materials and Methods
2.3.1 Fabrication of Phase-shift Nanoemulsions
PSNE are fabricated using a three step hydration, sonication, and extru-
sion procedure (Kopechek et al., 2012). Lipids 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] (ammonium salt) (DPPE-mPEG2000) (Avanti
Polar Lipids, Alabaster, AL, USA) were used as the main constituents of the lipid
shell at 9:1 molar ratio. DPPC is a neutral (zwitterionic), biocompatible phospho-
lipid and is a major component of lung surfactant. DPPE-mPEG2000 is composed
of a polyethylene glycol (PEG) chain conjugated to a phosphatidylethanolamine lipid
molecule. PEG-lipid conjugates have been used extensively to improve the circulation
times of liposome encapsulated drugs (Papahadjopoulos et al., 1991).
The lipids were weighed out in a 7 mL glass vial and dissolved with a small volume
of chloroform (v1 mL) (Sigma-Aldrich, St. Louis, MO, USA). The chloroform was
slowly evaporated with a gently stream of Argon to leave a thin lipid film on the
side of the vial. To remove residual chloroform, the vial was placed in a desiccator
overnight. The lipid film was then hydrated with phosphate buffered saline (PBS)
(Boston Bioproducts, Ashland, MA, USA) pre-heated to 50 ◦C and placed in a 50 ◦C
water bath for one hour with periodic vortexing and sonication in an ultrasonic bath
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(Cole-Parmer, Vernon Hills, IL, USA). The lipid vesicles were then sonicated using a
high power sonication tip (Sonic & Materials, Newtown, CT, USA) for 1 minute to
produce a clear solution of small lipid vesicles at a lipid concentration of 1 mg/mL.
Submicron perfluorocarbon emulsions were made by adding 100 µL of perfluo-
ropentane (PFP, 29 ◦C boiling point) (FluoroMed, L.P., Round Rock, Texas, USA)
to 3 mL of lipid solution and sonicating with a high power sonication tip in an ice wa-
ter bath. A pulsing regime was used, 10 seconds ON, 50 seconds OFF, for a total ON
time of 1 minute to prevent heating and vaporization of PFP. This opaque suspen-
sion was then added to 7 mL of PBS and extruded 10 times through two stacked 200
nm polycarbonate filters using a LIPEXTM Extruder (Northern Lipids Inc., Burnaby,
British Columbia). Excess lipid vesicles were removed by three centrifugal washes for
5 minutes at 3,000 g. Each time the PSNE pellet was resuspended with PBS. PSNE
were stored at 4 ◦C and used for up to one week.
2.3.2 Particle Sizing and Concentration
Tunable resistive pulse sensing (TRPS) with the qNano (Izon Science Ltd.,
Christchurch, New Zealand) was used to determine the size and concentration of
PSNE. The qNano allows particle-by-particle counting and sizing of submicron parti-
cles as they pass through a stretchable nanopore. A NP200 nanopore (diameter range:
100 to 400 nm) was used along with 200 nm carboxylated polystyrene standards of
known size and concentration for calibration. The PSNE were diluted a thousand-fold
in PBS and at least 1000 nanopore blockade events were recorded at three different
pressure driven flow regimes according to the manufacturers instructions. This was
repeated with 200 nm standards using the same instrument settings to determine the
size and concentration of PSNE.
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Figure 2·2: Experimental set-up for detection of acoustic emissions
during and after the acoustic droplet vaporization of phase-shift na-
noemulsions. Focused ultrasound transducers at three frequencies (1,
2.5, and 5 MHz) were used to sonicate a suspension of phase-shift na-
noemulsions with short (5 cycle) bursts of ultrasound. Acoustic emis-
sions during and after acoustic droplet vaporization were detected with
a broadband, cylindrically focused passive cavitation detector.
2.3.3 Acoustic Droplet Vaporization Threshold
The technique used for determining the ADV threshold relies on the fact that newly
formed microbubbles from ADV will scatter ultrasound much more effectively than
PSNE. As shown in Figure 2·2, a passive cavitation detector (PCD) was positioned
perpendicular to FUS transducer to capture side scattered acoustic emissions ema-
nating from the focal zone of the transducer. Short bursts of ultrasound (5 cycles)
were transmitted into a suspension of PSNE at 1, 2.5, and 5 MHz. Below the ADV
threshold there is only low amplitude scattering off surfaces along the propagation
path until the ADV threshold is reached, where the newly formed microbubbles will
scatter the incident ultrasound pulse strongly and will be detected by the PCD. Using
appropriate delays based on time-of-flight of the ultrasound pulse from the FUS trans-
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ducer to the PCD, acoustic emissions from the focal zone can be time and voltage
gated to determine if an ADV event is present in the PCD’s signal.
FUS transducers were submerged in a partially degassed, 37 ◦C water bath and
aligned confocally with a broadband, cylindrically focused PCD (Y-102, 10 kHz to 15
MHz operating bandwidth, Sonic Concepts, Bothell, WA, USA). Three transducers
were used to sonicate the PSNE suspension at 1 MHz (H-102, Sonic Concepts, Bothell,
WA, USA), 2.5 MHz (H-108, Sonic Concepts, Bothell, WA, USA), and 5 MHz (SU-
108, Sonic Concepts, Bothell, WA, USA). Free field pressure calibrations at the focal
spot were performed with a 75 µm needle hydrophone (Precision Acoustics, Dorch-
ester, Dorset, England). Peak negative pressure measurements were made up to 1
MPa and extrapolated out to higher pressures with a linear fit. The transducers were
driven using a 55 dB RF power amplifier (Electronics & Innovation, Rochester, NY,
USA) and waveform generator (Agilent Technologies Inc., Santa Clara, CA, USA).
PSNE were diluted into degassed (v30% dissolved Oxygen), deionized water inside
a custom made enclosure with acoustically transparent sides (TegadermTM, 3M, St.
Paul, MN, USA) at a concentration of 109 PSNE/mL and submerged into the heated
water bath. A magnetic stir bar was placed into the container for mixing of the PSNE
during experiments.
The pressure threshold for ADV of PSNE at each frequency was determined by
pulsing the PSNE suspension with 5 cycle pulses at a 100 Hz pulse repetition fre-
quency with increasing pressure. A peak negative pressure range of 4 to 8 MPa
was used for each ultrasound frequency. At each pressure step, the output from the
PCD was passed through a 15 MHz low pass filter (Allen Avionics Inc., Mineola, New
York, USA), pre-amplified 40 dB (Model DHPVA-100, Femto, Berlin, Germany), and
digitized at 50 MS/s with a 14 bit oscilloscope board (GaGe Corp., Lockport, IN,
USA). A total of 100 individual traces were captured at each pressure step for post
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processing. A custom MATLAB (Mathworks, Natick, MA, USA) program was used
for instrument control and automation of data collection and analysis. ADV of PSNE
was determined by defining a voltage threshold within the gated region of the PCD
time trace corresponding to acoustic emissions emanating from the focal zone of the
FUS transducer. Interrogation below the PSNE pressure threshold yielded very low
voltage scattering off surfaces along the propagation path. When the vaporization
threshold was reached, the voltage of PCD signal increased by more than ten fold due
to active scattering of the incident ultrasound wave by the newly created microbub-
ble. The data for each pressure step was defined as a percent of signals containing
a cavitation event and plotted versus peak negative pressure. Here we define cavi-
tation event and ADV of PSNE interchangeably, although, a cavitation event could
also result from cavitating the host liquid or any other stabilized gas bodies present.
Control experiments without PSNE were performed in partially degassed (v30% dis-
solved Oxygen), deionized water to identify the baseline amount of cavitation in the
host liquid. Additional control experiments were performed with perfluorohexane
(PFH) PSNE, which are expected to undergo ADV at much higher pressures than
PFP PSNE. Therefore, they serve as a control to ensure that the cavitation events
are not originating at the PSNE/host liquid interface.
2.3.4 Analysis of Acoustic Emissions
A PCD scheme similar to Ammi et al. (2006) was employed to analyze the acoustic
emissions from individual PSNE during and after ADV. Temporal features of the
PCD signal were analyzed to provide information about the microbubble growth,
collapse, and rebound following ADV of PSNE. Therefore, inferences can be made
about the microbubble dynamics following ADV and its relationship to excitation
frequency. PCD signals from each frequency were analyzed at the pressure that
resulted in v10% of the PCD’s signals having a cavitation event.
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Figure 2·3: An example signal from the passive cavitation detec-
tor showing the acoustic emissions from a single phase-shift nanoemul-
sion after acoustic droplet vaporization with a burst of ultrasound at 1
MHz (excitation waveform). Emissions occurring during the excitation
waveform are classified as principle excitation emissions, while emis-
sions occurring after passage of the excitation waveform are classified
as post-excitation emissions.
Figure 2·3 shows an example PCD signal from the acoustic emissions during the
ADV of PSNE using 1 MHz ultrasound. The principal excitation is defined as the
acoustic emissions that occur during the passage of the excitation waveform, while
post-excitation emissions occur after passage of the excitation waveform. Since these
emissions occur after the excitation waveform, they are hypothesized to arise from
the inertial collapse and rebound of the newly formed microbubble. Figure 2·4 is an
illustration of the proposed features seen in the PCD signals. The principal response
contains scatter at the incident waveform frequency, but also a collapse spike. It
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Figure 2·4: Hypothesized bubble dynamics following the acoustic
droplet vaporization of phase-shift nanoemulsions by analyzing the tem-
poral features of the passive cavitation detector.
is assumed that nucleation occurs during the peak negative cycle of the excitation
waveform and the microbubble immediately undergoes growth followed by a first
collapse as the peak positive cycle returns. The microbubble then undergoes another
growth phase during the subsequent peak negative cycle, gaining enough momentum
to continue through the remainder of the excitation waveform and reach a maximum
radius (Rmax) after passage of the wave. At this point the microbubble has reached
Rmax and experiences an unforced collapse due to the in-rushing liquid surrounding
the microbubble. Ensuing rebounds and collapses occur after the main collapse from
Rmax.
Theory
Simplifying the role of the excitation waveform as the force needed to drive the mi-
crobubble to Rmax, the temporal features of the PCD time traces can be used to
26
estimate Rmax using the Rayleigh collapse model (Rayleigh, 1917). This model was
derived by Lord Rayleigh, which considered the collapse of an empty cavity (no gas
or vapor) located inside an incompressible fluid. By equating the kinetic energy of
the liquid mass, to the work done by the hydrostatic pressure in collapsing the cav-
ity, an equation for the bubble wall velocity can be reached. Upon integration from
Rmax to zero, with respect to time, the collapse time (tc) of the cavity can be found.
Rearranging the equation, the maximum radius (Rmax) is defined as:
Rmax =
tc
√
P0
ρ
0.915
(2.1)
where tc, P0, and ρ are the collapse time, hydrostatic pressure, and liquid density,
respectively. As stated by Neppiras (1980), this is the simplest model for a collapsing
spherical cavity and all transient cavities start their collapse like this, hence they are
called Rayleigh-like. Equation 2.1 was used to predict the maximum radius of the
microbubbles after ADV by equating the time delay between the principle excitation
and first post-excitation emission as 2tc.
Apfel (1981) derived an analytical estimate for the maximum size of a bubble to
predict the threshold for inertial cavitation:
Rmax =
4
6pif
(PA − P0)
√
2
ρPA
[
1 +
2
3P0
(PA − P0)
]1/3
(2.2)
where f , PA, P0, and ρ are the frequency, acoustic pressure, hydrostatic pressure,
and liquid density, respectively. This estimate is only valid if the acoustic period is
much shorter than the start-up times associated with inertial and viscous effects as
described in Section 1.2. This estimate is insensitive to the equilibrium radius, R0,
and is mainly for bubbles that are much less than the resonance size (Leighton, 1994).
Equation 2.2 was used to compare with predictions of Rmax using Equation 2.1. Since
Equation 2.2 doesn’t rely on experimental approximations similar to Equation 2.1, it
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may be more accurate in predicting Rmax.
2.4 Results
A representative PSNE size distribution is shown in Figure 2·5. The emulsification
followed by high pressure extrusion procedure yielded a fairly monodisperse popula-
tion of PSNE with a typical bulk concentration of 2.0 × 1011 PSNE/mL. Common
values for the mean diameter and modal diameter are 213 nm (standard deviation
= 31.4) and 203 nm (+/- 2.2) respectively. The d10, d50, and d90 values were 180.1,
208.7, and 250.4 nm respectively. These values result in a d90/d10 value of 1.4 and
a span of 0.3. It is possible to reduce the mean size further during extrusion using
filters with smaller pore sizes, such as 50 and 100 nm diameter pores.
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Figure 2·5: Phase-shift nanoemulsion size distribution as measured
with tunable resistive pulse sensing. Typical values for the mean di-
ameter and concentration are 213 nm (standard deviation = 31.4) and
2.0× 1011 PSNE/mL.
Figure 2·6 shows results for determination of the ADV pressure threshold for PFP
PSNE at 1, 2.5, and 5 MHz. As the pressure was increased for all frequencies, there
was an increasing occurrence of cavitation events until a saturation with v100% of
the signals containing a cavitation event. A sigmoidal curve was used to fit the data.
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Control experiments with PFH PSNE or no PSNE (water) yielded limited events,
which was mainly due to the inability to have perfectly clean, filtered water with no
stabilized gas bodies. The time gate of the PCD signal used for the voltage thresh-
old corresponded to the region with the principal excitation from the microbubble as
shown in Figure 2·3. It is important to note that if the time gate was applied only
to the post-excitation region, the same results would be seen (data not shown). This
means that once the ADV threshold for PSNE is reached, the microbubbles imme-
diately undergo extensive growth and collapse. Table 2.2 shows the peak negative
pressure thresholds that resulted in approximately v10% of the PCD’s signals having
a cavitation event.
Looking at the individual PCD signals at this v10% threshold pressure, the tem-
poral features of the PCD signals were compared across frequencies. Figures 2·7, 2·8,
and 2·9 display representative signals detected by the PCD at 1, 2.5, and 5 MHz
respectively. Each figure includes three parts: (A) The transmitted waveform from
the FUS transducer; (B) PCD signal; and (C) the power spectrum of the PCD signal
and reference signal with no PSNE present. The PCD signal for each frequency was
time delayed to match up with the transmitted waveform based on time of flight
measurements. The exact position of the emissions relative to the phase of the trans-
mitted pulse could not be obtained, so the time delay was adjusted so the first collapse
lined up with the peak positive of the transmitted waveform. In any case, the post-
exitation emissions occured well after the passage of the transmitted waveform. The
PCD signal at each frequency was further analyzed by determining the time between
the principle excitation and post-excitation emissions. Approximating this value to
2tc, the Rmax of the microbubbles were estimated using Equation 2.1. Table 2.2 shows
the results for these values at each frequency.
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Figure 2·6: Acoustic droplet vaporization pressure threshold of per-
fluoropentane phase-shift nanoemulsions using 5 cycle bursts of ultra-
sound at 1, 2.5, and 5 MHz. A voltage threshold was applied to the
signals collected by the passive cavitation detector and reported as a
percent (%) of signals containing a cavitation event. This was done
over a range of peak negative pressures at each frequency. Control ex-
periments were performed with no phase-shift nanoemulsions (water)
and with perfluorohexane phase-shift nanoemulsions.
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Figure 2·7: Acoustic emissions detected by passive cavitation detec-
tor during and after the acoustic droplet vaporization of an individual
phase-shift nanoemulsion at 1 MHz. (A) Transmitted waveform from
the focused ultrasound transducer recorded by a needle hydrophone
at v1 MPa. (B) Acquired signal from the passive cavitation detec-
tor depicting acoustic emissions from a single phase-shift nanoemulsion
during and after acoustic droplet vaporization. (C) Power spectrum of
passive cavitation detector signal from (B).
Frequency Peak Negative Pressure Collapse Time (tc) Estimated Rmax
1 MHz 5.62 MPa 5.59 µs (+/- 0.47) 61.71 µm (+/- 5.16)
2.5 MHz 5.91 MPa 2.25 µs (+/- 0.25) 24.86 µm (+/- 2.75)
5 MHz 4.63 MPa 1.125 µs (+/- 0.19) 12.42 µm (+/- 2.06)
Table 2.2: Peak negative pressure resulting in v10% of the pas-
sive cavitation detector’s signals having a cavitation event for each
frequency, along with the collapse time and estimated Rmax at that
pressure.
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Figure 2·8: Acoustic emissions detected by passive cavitation detec-
tor during and after the acoustic droplet vaporization of an individual
phase-shift nanoemulsion at 2.5 MHz. (A) Transmitted waveform from
the focused ultrasound transducer recorded by a needle hydrophone
at v1 MPa. (B) Acquired signal from the passive cavitation detec-
tor depicting acoustic emissions from a single phase-shift nanoemulsion
during and after acoustic droplet vaporization. (C) Power spectrum of
passive cavitation detector signal from (B).
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Figure 2·9: Acoustic emissions detected by passive cavitation detec-
tor during and after the acoustic droplet vaporization of an individual
phase-shift nanoemulsion at 5 MHz. (A) Transmitted waveform from
the focused ultrasound transducer recorded by a needle hydrophone
at v1 MPa. (B) Acquired signal from the passive cavitation detec-
tor depicting acoustic emissions from a single phase-shift nanoemulsion
during and after acoustic droplet vaporization. (C) Power spectrum of
passive cavitation detector signal from (B).
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2.5 Discussion
The ability to reduce the polydispersity of the PSNE size distribution allows for
uniform characterization of the ADV process. A very distinct pressure threshold
window can be seen for PSNE at all frequencies, where the detected cavitation events
go from 0% - 100% over a v0.5 MPa window. Fabiilli et al. (2009) showed a similar
sigmoidal shaped threshold curve for ADV of micron sized PFC droplets, but the 0%
- 100% threshold region was spread out over larger pressures ranges. This may be due
to the large polydispersity seen with high speed shaking and sonication fabrication
techniques, where the size dependence of the ADV threshold broadens the threshold
region. The narrow pressure threshold for ADV of PSNE may provide a more precise
way to initiate acoustic cavitation in an all or none manner.
Numerous researchers have employed similar detection and analysis schemes dur-
ing single bubble sonoluminescence (Matula et al., 1998), collapse of lithotripsy bub-
bles (Cleveland et al., 2000; Kreider et al., 2011), and inertial cavitation of ultrasound
contrast agents (Ammi et al., 2006; King et al., 2010; King and O’Brien, 2011). The
observed collapse spikes or post-excitation acoustic emissions are hypothesized to
arise from emitted shockwaves during the collapse and rebound of bubbles. There-
fore, these features represent a distinct acoustic signature of inertial cavitation. This
is the first study to look at the relationship between the excitation frequency and the
resultant post-excitation emissions from bubbles formed via ADV of PFC droplets. If
we assume the phase conversion process happens on a much faster time scale than the
acoustic cycle, the frequency dependence of the post-excitation can be explained with
general acoustic cavitation theory described in Section 1.2. According to the ideal
gas law, phase change of PSNE will result in a microbubble that is approximately
five times the original diameter of the PSNE (Sheeran et al., 2011). This assumes all
the perfluorocarbon is transitioned into vapor and there is no influx of water vapor or
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dissolved gas from the surrounding medium. A 200 nm diameter PSNE will transi-
tion into a 1 µm diameter microbubble with a free bubble resonant frequency of v10
MHz. Therefore, it is hypothesized that the microbubbles formed from PSNE are
small enough to respond rapidly during the acoustic periods used in this study and
reach significant expansion ratios (i.e. Rmax/R0). Since the acoustic period varies
with frequency, the microbubbles have more time to grow during the rarefactional
period of lower frequencies. Hypothetically, this results in the increased collapse time
and therefore Rmax with decreasing frequencies from 5 to 1 MHz.
Following the derivation of Apfel (1981), Equation 2.2 can be used to compare
with the predicted Rmax values using the Rayleigh collapse model (Equation 2.1).
The start-up time associated with viscous effects can be neglected since the driving
pressure is very high (Apfel, 1981; Holland and Apfel, 1989). Apfel (1981) derived
an equation for the inertial radius, RI , such that bubbles smaller than this size can
grow significantly during less than half of an acoustic cycle:
RI ≈ 1
4f
√
PA − P0
ρ
(2.3)
where f , PA, P0, and ρ are the frequency, acoustic pressure, hydrostatic pressure,
and liquid density, respectively. For the frequencies used in this study, RI approxi-
mates to 22.3 µm, 9.2 µm, and 4 µm for 1 MHz, 2.5 MHz, and 5 MHz, respectively.
Therefore, the predicted R0 of 0.5 µm for PSNE using the ideal gas law is less than
the inertial radius for all frequencies. Equation 2.2 can therefore be used to predict
Rmax at the v10% threshold pressure reported in Table 2.2. It estimates a Rmax of
73.9 µm, 30.9 µm, and 12.5 µm for 1 MHz, 2.5 MHz, and 5 MHz, respectively. This
is in good agreement with the estimated Rmax values that were reported in Table 2.2.
This confirms the hypothesis that microbubbles formed from PSNE are small enough
to reach significant expansion ratios during the rarefactional period of the ultrasound
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pulse.
Additional control of the microbubble expansion ratio could also be achieved by
the choice of perfluorocarbon. Numerous researchers have shown that PSNE can be
formulated with PFC mixtures and PFCs with lower boiling points (Kawabata et al.,
2005; Sheeran et al., 2012). This reduces the required pressure for ADV and the
microbubbles will therefore experience less tension during the peak negative cycle of
the ultrasound wave. It is expected that this will lower the expansion ratio of the
microbubbles, possibly to an extent to eliminate inertial collapse. Higher frequencies
(>5 MHz) could also produce a similar effect by limiting the amount of time the
microbubble has to grow during the acoustic period.
As mentioned in Section 2.2.2, studies with micron-sized PFC droplets have
showed contradictory results with bubbles formed after ADV. Stable bubble oscilla-
tions with non-inertial collapse has been consistently seen in studies using optical and
acoustic based techniques (Shpak et al., 2013a; Sheeran et al., 2014). PFC droplets
with diameters ranging from 1-10 µm would result in bubbles with diameters of ap-
proximately 5 - 50 µm, respectively. The resonant frequencies of these bubbles would
be 1.35 to 0.1 MHz and therefore might not respond rapidly to an ultrasound pulse in
the frequency range of 1 to 10 MHz. In this situation, the bubble would be insonified
above its resonant frequency in a mass-controlled regime. This would explain the
studies by Fabiilli (2009) that have shown ADV of micron-sized PFC droplets can
occur with or without inertial cavitation. For the large bubbles formed from ADV of
micron sized droplets, inertial effects dominate the initial growth, which increases the
inertial cavitation threshold. It takes much more force (pressure differential across
bubble wall), on longer time scales (acoustic periods), to achieve significant expansion.
Contrastingly, the smaller microbubbles formed from ADV of PSNE have ample time
during the acoustic periods used in this study to reach significant expansion ratios.
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Further analysis of the post-excitation emissions in Figure 2·3 show that the in-
terval between the post-excitation emissions, representing the main collapse post va-
porization and subsequent collapses after bubble rebound, are much longer than the
period of the predicted microbubble resonance (0.1 µs for predicted 1 µm bubble).
This elongated first rebound has been seen in previous studies with single bubble
sonoluminescence and might be explained by vapor trapping (Storey and Szeri, 2000;
Matula et al., 2002). During the isothermal growth of the microbubble there is a large
intake of water vapor that becomes trapped during the rapid, adiabatic collapse. This
effectively increases the equilibrium radius and resonant period of the microbubble,
resulting in the elongated first rebound. Figure 2·3 shows a decrease in the rebound
period out to the third collapse. This could be explained by vapor gradually escap-
ing, making the rebounds successively shorter. The vapor could act to cushion the
microbubble collapse and therefore reduce its violence. This could be beneficial de-
pending upon the desired bioeffect or detrimental if an energetic collapse is needed.
Lastly, the cushioned collapse could decrease the likelihood of bubble fragmentation
and destruction. This could have important implications for contrast-enhanced ul-
trasound imaging with PSNE where stable, nonlinear oscillations are utilized (Reznik
et al., 2011).
2.5.1 Limitations
High-speed microscopy of the microbubble dynamics following ADV of PSNE would
be necessary to fully verify the acoustic emissions seen in this study. The hypoth-
esis that the post-excitation emissions are from the inertial collapse and rebound
of a microbubble are corroborative with other studies that detected similar acoustic
emissions (Ammi et al., 2006; King et al., 2010; King and O’Brien, 2011). The fact
that the emissions occurred after the ultrasound wave, at increasing times, with lower
frequencies, supports the hypothesis. It can be confidently concluded from the data
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that the Rmax of the microbubble increases with lower frequencies. The assumptions
that go into the Rayleigh collapse time described in Section 2.3.4, limits the calcu-
lated Rmax to an approximation. The effects of gas and vapor inside the microbubble
during collapse are not included in the derivation, where more work would be needed
by the hydrostatic pressure to compress the gas. As a first approximation, estimating
Rmax from tc using Equation 2.1 allows for examining the impact of the acoustic wave
period on the bubble dynamics after vaporization.
The standard value to describe the collapse intensity of a microbubble is the ex-
pansion ratio (Rmax/R0). The equilibrium radius of the microbubble is unknown
throughout the ADV process and might change depending on gas/vapor influx from
surroundings. Therefore, it is not possible to verify that the expansion ratio also
increases with lower frequencies. Comparing the amplitudes of the post-excitation
spikes in the PCD signals, the peak amplitude increases with decreasing frequency.
The collapse intensity and therefore emitted shockwave amplitude is expected to
increase with increasing expansion ratios. So, assuming the PCD amplitude is pro-
portional to the acoustic emission strength, it suggests that the expansion ratio also
increases for lower frequencies (assuming the transmitted pressure is equal across
frequencies).
It should be noted that the pressures reported in this study (and subsequent
chapters) were determined by extrapolating a low pressure (less than 1 MPa), free
field calibration of the FUS transducer measured with a needle hydrohone. The exact
waveform shape and pressure amplitudes could not be obtained due to the possibility
of cavitation damaging the hydrophone a the high acoustic outputs used to vaporize
PSNE. A more appropriate technique would be the use of a fibre-optic hydrophone
which can withstand the high pressures used in this study.
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2.6 Conclusion
The monodispersity, precise ADV threshold, and frequency-dependence of the bub-
bles dynamics following ADV provides a unique acoustic cavitation nucleation agent.
The transition from stable to transient (inertial) cavitation with UCAs has been stud-
ied extensively and can vary greatly depending on the UCA formulation (mean size
and polydispersity) and ultrasound parameters, most notably frequency and pres-
sure. Therefore, an acoustic cavitation agent that goes inertial at a very defined
pressure threshold, with predictable dynamics based on frequency, would help elimi-
nate variability seen with polydisperse UCA microbubble populations. These results
highlight the importance of ultrasound frequency on the microbubble dynamics of
PSNE after ADV. At the frequencies and ADV pressures used in this study, sig-
nificant bubble growth was observed after PSNE vaporization by the detection of
collapse and rebound acoustic emissions after passage of the ultrasound pulse. More
extensive microbubble growth was achieved at lower frequencies. It is hypothesized
that control over expansion ratio of vaporized PSNE may be achieved by selection of
the ultrasound frequency. The next chapter will test the hypothesis that bioeffects
caused by collapsing microbubbles from PSNE are dependent on the expansion ratio.
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Chapter 3
Frequency-Dependent Sonoporation
Efficiency with Phase-shift Nanoemulsions
3.1 Scope
As shown in Chapter 2, the microbubble dynamics following ADV of PSNE can be
controlled (i.e. the maximum radius (Rmax) and expansion ratio (Rmax/R0) of the
microbubble) with the choice of the ultrasound frequency. This chapter tests the
hypothesis that uptake efficiency during sonoporation is dependent on the choice of
ultrasound frequency. Lower frequencies should produce larger expansion ratios and
more extensive cell death upon collapse. Uptake efficiency takes into account cell
viability and is defined as the total number of viable cells showing uptake, divided by
the total number of cells originally in the sample. An experimental investigation was
carried out using a suspension of human breast cancer cells (107 cells/mL) contain-
ing PSNE (109 PSNE/mL) and biomolecule FITC-dextran (v20 kDa, 10 µM molar
concentration). Focused ultrasound was applied to the suspension at 1, 2.5, and 5
MHz with fixed settings (6.5 MPa peak negative pressure, 5 cycle pulses, 250 Hz pulse
repetition frequency, and 100 second exposure duration). Flow cytometry and cell
proliferation assay analysis revealed that the sonoporation efficiency with PSNE is
highly dependent on the choice of ultrasound frequency.
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3.2 Background
3.2.1 Sonoporation
The use of oscillating microbubbles to temporarily disrupt the cell membrane has a
long history within the field of therapeutic ultrasound (Kooiman et al., 2014). Ideally,
the goal is to porate the cell’s outer membrane to allow biomolecules to diffuse into
the cell’s cytoplasm, while keeping the cell alive. Intracellular delivery of a wide range
of biomolecules has been achieved with sonoporation, including DNA, RNA, drugs,
proteins, and other small biomolecules (Lentacker et al., 2014). Although, it has
been a difficult task to do this efficiently in an in vitro setting (i.e. delivery to a large
amount of cells without killing a large fraction). Researchers have therefore explored
numerous experimental and ultrasound parameters in an attempt to produce efficient
delivery. Mild conditions (e.g. low acoustic pressures and stable cavitation) may
keep a large majority of the cells alive, but biomolecule uptake might be minimal.
Conversely, harsh conditions may produce uptake in a large majority, but obliterate
a large fraction. This sort of trade-off is common with other methods of intracellular
delivery, such as chemical and physical methods (Davalos et al., 2000; Barry, 2004;
Osada et al., 2006).
When referring to the harshness or mildness of sonoporation, it is usually described
as the type of acoustic cavitation activity. Lentacker et al. (2014) categorized the
mechanisms of sonoporation into three categories: 1) low intensity ultrasound caus-
ing stable cavitation, 2) high intensity ultrasound causing inertial cavitation, and 3)
ultrasound application in the absence of microbubbles. As described in Section 1.2.2,
the type of acoustic cavitation activity can be related to the severity of the bioef-
fect. Inertial cavitation has been linked to numerous erosive effects caused by high
bubble wall velocities, high temperatures and pressures on collapse, micro-jetting,
and shockwave emission (Neppiras, 1980; Leighton, 1994). Stable cavitation can be
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categorized as a more gentle mode of acoustic cavitation and can radiate pressure
into the surrounding fluid to cause microstreaming effects (Wu and Nyborg, 2008).
With both modes of acoustic cavitation, the cell’s membrane experiences shear stress
that can permeabilize the membrane for biomolecule uptake. Figure 3·1 illustrates
an inertial cavitation event near a cell membrane, where the emitted shockwave upon
collapse can lead to cell membrane disruption.
R
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Collapse
Cell’s Cytoplasm
Shockwave
Figure 3·1: Illustration of the growth, collapse, and shockwave emis-
sion of a microbubble near a cell membrane. Ultrasound can be used
to grow microbubbles to many times their initial radius (R0) to a maxi-
mum radius (Rmax). The microbubbles then collapse due to the inrush-
ing liquid surrounding the microbubble, leading to high temperatures,
pressures, and shockwave emission.
Researchers have used passive cavitation detection and optical methods during
sonoporation experiments to quantify the type of acoustic cavitation activity for cor-
relation with biomolecule uptake and cell death (Hallow et al., 2006; Lai et al., 2006;
van Wamel et al., 2006; Forbes et al., 2008; Zhou et al., 2008a; Qiu et al., 2010;
Forbes et al., 2011; Zhou et al., 2012; Fan et al., 2014). While inertial cavitation
has been used predominately in sonoporation studies, Forbes et al. (2011) suggested
that sonoporation is related to linear and/or non-linear oscillation of UCAs, which
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occured below the inertial cavitation threshold. Other researchers such as Hallow
et al. (2006) and Lai et al. (2006), showed direct correlation of inertial cavita-
tion with sonoporation activity. Uptake and viability were directly related to the
inertial cavitation dose, with increasing uptake and decreasing viability at higher in-
ertial cavitation doses. Using high-speed imaging, Fan et al. (2014) characterized
the acoustic cavitation activity during sonoporation into three categories: (1) stable
cavitation/aggregation, (2) growth/coalescence and translation and (3) inertial cavi-
tation. Their results showed that growth/coalescence and translation was responsible
for cell death, where as inertial cavitation was necessary for intracellular delivery and
cell survival.
The cell response after sonoporation has been investigated by numerous re-
searchers, which have described cell membrane morphology changes after exposure
to acoustic cavitation (Schlicher et al., 2006; Zhao et al., 2008; Kudo et al., 2009;
Schlicher et al., 2010; Chen et al., 2014; Leow et al., 2015). Sonoporation may also
induce numerous cellular bioeffects, such as affecting the cell’s membrane potential
(Tran et al., 2007; Tran et al., 2008), modulating intracellular calcium ion signals (Ku-
mon et al., 2007; Fan et al., 2010; Park et al., 2010), increasing free radical production
(Juffermans et al., 2006; Hassan et al., 2009; Okada et al., 2009), and cytoskeleton
disruption (Chen et al., 2014). Sonoporated cells must cope with these stresses and
heal in order to remain viable after exposure to acoustic cavitation. Cell membrane
resealing is crucial for cell survival and researchers have shown that resealing takes
place within seconds of exposure through a calcium ion-mediated mechanism that
involves resealing of the permeablized site with intracellular vesicles (Zhou et al.,
2008b; Hassan et al., 2010; Hu et al., 2013). Resealing does not necessary imply cell
survival, as anti-proliferative effects such as apoptosis (Miller and Dou, 2009), cell
cycle arrest (Zhong et al., 2011), and suppression of cloneogenicity (Karshafian et al.,
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2010) can arise after exposure.
In principle, the majority of delivered bioactive molecules/compounds require a
live cell post-delivery in order to be effective. For example, DNA must traffic to the
nucleus for gene expression and other molecules like RNAs and proteins utilize cellular
machinery in the cytoplasm. Therefore, it is useful to question whether sonoporation
can deliver agents efficiently without killing the majority of cells. Liu et al. (2012)
performed a recent retrospective literature review and analysis to ask that specific
question: can ultrasound enable efficient intracellular uptake of molecules? Their
analysis concluded that the answer is no, efficient intracellular uptake of molecules
cannot be achieved with ultrasound and microbubbles. While some studies have
shown it is possible, improper experimental methods have yielded misleading results.
Specifically, in regards to accounting for lysed cells when defining cell viability. Most
researchers do not account for this mode of cell death in their experimental methods
and report higher uptake efficiencies than what was achieved. The subsequent sections
will explore the feasibility of using PSNE as efficient acoustic cavitation nuclei for
sonoporation.
3.3 Materials and Methods
The methods in this chapter will follow the convention put forth by Liu et al. (2012) as
described in Section 3.2.1. A suspension of cells containing PSNE and FITC-dextran
(mock biomolecule) were exposed to FUS above the ADV threshold of PSNE at 1,
2.5, and 5 MHz. Flow cytometry analysis after the ultrasound exposure was used to
determine the uptake efficiency of FITC-dextran. A cell proliferation assay was also
performed 24 hours post-ultrasound exposure as another metric of cell viability and
is sensitive to how well the cells recover over time (i.e. proliferate). The combination
of both methods should identify all modes of cell death following the ultrasound
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exposure (i.e. necrosis, apoptosis, fragmentation, and cell lysis).
3.3.1 Experimental Set-up
As shown in Figure 3·2, the experimental set-up consisted of a FUS transducer sub-
merged in a partially degassed, deionized water bath heated to 37 ◦C. A three axis
micrometer positioning system (ThorLabs Inc., Newton, New Jersey, USA) was used
to manipulate the transducer’s position and place the focus within the cell suspension.
The cell suspension was housed in a 1.5 mL polypropylene microcentrifuge tube and
submerged into the water bath. This provided a sterile environment inside the tube,
while keeping an acoustic path for transmission of ultrasound into the suspension.
Focal placement was achieved using micron sized PFC droplets for visualization of
the focal volume using the resultant bubble cloud after ADV. After initial placement
with this technique, PSNE were used for final adjustments. Since the acoustic cavi-
tation activity is constant above the ADV threshold for PSNE, a PCD set-up similar
to Section 2.3.3 was used while positioning to identify when the focus was no longer
inside the suspension in all three axes. Using the travel distances on the micrometer,
the focus was then placed in the middle of these extremes in all three axes.
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Figure 3·2: Experimental set-up for testing the frequency dependent
sonoporation efficiency with phase-shift nanoemulsions with ultrasound
at 1, 2.5, and 5 MHz. Focused ultrasound transducers were submerged
in a 37 ◦C water bath and the focal volume was positioned in a cell
suspension (25µL) containing phase-shift nanoemulsions (109/mL) and
FITC-dextran (10µM). Ultrasound parameters consisted of 6.5 MPa
peak negative pressure, 5 cycle pulses, 250 Hz pulse repetition fre-
quency, and 100 second exposure duration.
Three FUS transducers were used to sonicate the cell suspension at 1 MHz (H-102,
Sonic Concepts, Bothell, WA, USA), 2.5 MHz (H-108, Sonic Concepts, Bothell, WA,
USA), and 5 MHz (SU-108, Sonic Concepts, Bothell, WA, USA). The transducers
were driven using a 55 dB RF power amplifier (Electronics & Innovation, Rochester,
NY, USA) and waveform generator (Agilent Technologies Inc., Santa Clara, CA,
USA). Using the results from Section 2.4, a peak negative pressure of 6.5 MPa was
used for all frequencies. This pressure is above the PSNE ADV threshold for all
frequencies and resulted in consistent ADV of PSNE (i.e. 100% of the PCD’s signals
contained cavitation events). Similarly, the ultrasound parameters used were 5 cycle
pulses, 250 Hz pulse repetition frequency, and a 100 second treatment duration. A
custom MATLAB (Mathworks, Natick, MA, USA) program was used for instrument
control and automation of data collection.
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3.3.2 Cell Suspension
Human breast adenocarcinoma cells (MDA-MB-231) were grown to confluence in
75 cm2 tissue culture flasks. Dulbecco’s Modification of Eagle’s Medium (DMEM)
(Mediatech Inc., Manassas, VA, USA) was used as the culture medium and was sup-
plemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals Inc., Flowery
Branch, GA, USA), 2% L-glutamine (200 mM stock) (Mediatech Inc., Manassas, VA,
USA), and 1% penicillin streptomycin (5 mg/mL stock) (Mediatech Inc., Manassas,
VA, USA). Cells were harvested using trypsin-EDTA (0.25% stock) (Mediatech Inc.,
Manassas, VA, USA) and counted using a hemacytometer (Hausser Scientific, Hor-
sham, PA, USA). Cell culture media without FBS was used to re-suspend the cells
at a concentration of 1.316 × 107 cells/mL. Aliquots of 250,000 cells (19 µL) were
added to 1.5 mL microcentrifuge tubes and incubated at 37 ◦C. Prior to exposure
with ultrasound, cells were mixed with PSNE (1 µL) and FITC-dextran (5 µL) at a
concentration of 109 PSNE/mL and 10 µM FITC-dextran. The final volume of the
cell suspension was 25 µL. FITC-dextran was used as a mock bioactive agent and has
a similar molecular weight (v20 kDa) to siRNA.
3.3.3 Phase-shift Nanoemulsion Dynamics
The frequency-dependent dynamics of PSNE after ADV as seen in Chapter 2 were
further illustrated using the experimental set-up and methods described in Chapter
2. Using the ultrasound parameters for sonoporation experiments, PCD data was
collected over an entire mock sonoporation treatment duration using the experimental
set-up in Figure 2·2. Since the same concentration of PSNE were used, the detected
emissions can serve as a representation of the PSNE dynamics during sonoporation
experiments.
A typical PCD signal during the ADV of PSNE using 6.5 MPa peak negative pres-
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sure pulses of ultrasound at 1 MHz is shown in Figure 3·3A. Numerous post-excitation
collapse spikes can be seen at 10-35 µs and represent numerous microbubble collapses
after the principal excitation emission. The corresponding voltage envelope of the
PCD signal with PSNE is shown in Figure 3·3B. In order to illustrate the tempo-
ral dependence of cavitation activity between frequencies, the voltage envelopes were
summated over the exposure duration for each frequency. This provides information
related to when the cavitation activity occurred (i.e. collapse times) and the strength
of the cavitation activity (i.e. cumulative signal strength). The same PCD set-up
(filtering and pre-amplifier settings) were used for all frequencies so that the cumu-
lative signal strength values can be compared between frequencies. The cumulative
strength curves were further analyzed by numerical integration of the regions corre-
sponding to the principal and post-excitation emission with respect to time. This
provides a single value corresponding to the total amount of signal strength detected
by the PCD over the treatment duration.
3.3.4 Analysis
Immediately after the ultrasound exposure, fresh cell culture media was added to the
cell suspension and allowed to incubate at room temperature for at least 5 minutes.
Cells were then washed with PBS and resuspended with cold PBS at a concentration
of 106 cells/mL. Propidium iodide (PI) was added at a concentration of 4 µg/mL
to fluorescently tag non-viable cells. Live cells are impermeable to PI, where as
compromised cells (i.e. unable to repair their cell membrane) are permeable to PI.
Cells were incubated on ice for 15 minutes prior to flow cytometry analysis (FACS
Calibur, BD Biosciences, San Jose, CA, USA). Assuming the flow cytometer operates
at a constant flow rate, data was collected for one minute to compare the total number
of cells counted between control and treatment groups. All groups consisted of at least
three replicates.
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Figure 3·3: Example time trace from the passive cavitation detector
during the acoustic droplet vaporization of phase-shift nanoemulsions
using 1 MHz focused ultrasound at 6.5 MPa peak negative pressure.
(A) Passive cavitation detector signal with and without phase-shift na-
noemulsions showing multiple post-excitation emissions and (B) volt-
age envelope of passive cavitation detector signal with phase-shift na-
noemulsions.
The ability of cells to replicate was tested using an colorimetric assay to access
metabolic activity (i.e. signal strength correlates with the number of cells). Cells used
for the cell proliferation assay (MTT Cell Proliferation Assay, ATCC, Manassas, VA,
USA) were processed in a similar fashion, except cells were resuspended with 1 mL
of cell culture media after washing with PBS. Cells (treated and controls) were then
added to a 12 well tissue culture microplates and placed in the incubator. The MTT
assay was performed 24 hours post ultrasound exposure according the manufacturer’s
instructions.
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Bioeffect Quantification using Flow Cytometry
Cells were first gated on the forward scatter (FSC) vs. side scatter (SSC) plot and
the total number of cells in this gate contained all cells both viable and non-viable.
These cells were further analyzed using the FL1 (green channel, FITC dextran) vs.
FL3 (red channel, PI) scatter plot as shown in Figure 3·4.
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Figure 3·4: Example FL-1 (green channel, FITC-dextran) vs. FL-3
(red channel, propidium iodide) scatter plot and gated threshold regions
for flow cytometry data.
A fluorescence threshold gate was used to find the total number of viable cells (i.e.
cells showing low levels of red fluorescence). Cell viability was defined as:
Cell Viability (%) =
(
total number of viable cells
total number of cells in control
)
∗ 100 (3.1)
Looking at only viable cells, the total number of cells showing uptake was deter-
mined by defining a threshold fluorescence value on the same FL1 (green channel) vs.
FL3 (red channel) scatter plot. Uptake was defined as:
Uptake (%) =
(
total number of viable cells with uptake
total number of viable cells
)
∗ 100 (3.2)
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Finally, to account for cell viability in determination of uptake, the uptake effi-
ciency was defined as:
Uptake Efficiency (%) =
(
total number of viable cells with uptake
total number of cells in control
)
∗ 100 (3.3)
The control groups consisted of cells that were mixed with PSNE and FITC-
dextran, but not exposed to ultrasound. The value used for the total number of cells
in control was an average value from at least three separate control cell populations.
Cell viability, uptake, and uptake efficiency were determined for all exposures with at
least three replicates performed for each group. The values reported are the means
along with the standard deviation. Student’s t-test was applied to the data with a
p < 0.05 considered significant.
3.4 Results
Figure 3·5 shows the results for the cumulative signal strength from the PCD at each
frequency. Figure 3·5A shows the cumulative signal strength over the entire acoustic
emission window of the PCD, while Figures 3·5B and 3·5C are zoomed to the regions
corresponding to the principal excitation and post-excitation emissions, respectively.
The peak and width of the cumulative signal strength from the principal excitation
increased with decreasing frequency. Contrastingly, the peaks in the post-excitation
region showed less correlation with frequency, with the highest peak at 1 MHz and
lowest at 2.5 MHz. However, the position of the peak for the cumulative signal
strength of the post-excitation region occurred later in time for lower frequencies rel-
ative to the beginning of the principal excitation. This represents an overall increase
in the collapse time of microbubbles at lower frequencies, and suggests that the mi-
crobubbles reached greater maximum radii as the frequency was decreased. Overall,
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the integrated cumulative signal strength over the entire treatment and during the
post-excitation region increased with decreasing frequency as shown in Table 3.1. The
importance here is that the overall acoustic emission strength during the sonopora-
tion experiments increased with decreasing frequencies, which suggests microbubbles
were collapsing more violently at lower frequencies.
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Figure 3·5: Cumulative signal strength at each frequency detected by
the passive cavitation detector during a mock sonoporation exposure
using the experimental set-up in Chapter 2. (A) Cumulative signal
strength over the entire acoustic emission window, (B) during the prin-
cipal excitation and (C) during the post-excitation emission region.
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Name Integrated Cumulative Integrated Cumulative
Signal Strength Signal Strength (Post-Excitation)
1 MHz 4.91×105 V · s 1.08×105 V · s
2.5 MHz 1.52×105 V · s 0.36×105 V · s
5 MHz 0.68×105 V · s 0.27×105 V · s
Table 3.1: Compiled results for the integrated cumulative sig-
nal strength for the entire signal and region corresponding to post-
excitation emissions for all frequencies.
Representative scatter plots of the flow cytometry data are shown in Figure 3·6.
Figure 3·6A-C are the control cell populations for 1, 2.5, and 5 MHz, while Figure
3·6D-F are the treated cell population for 1, 2.5, and 5 MHz, respectively. Low
FITC-dextran uptake is seen in the control cells, while extensive uptake was seen
with treated cells. Looking at the controls, two distinct cell populations exist, live
cells with low PI fluorescence and non-viable cells with high PI fluorescence. The
amount of non-viable cells in the control populations was typically around 5% and
was most likely due to cell death during cell preparation. The treated cells at 5 MHz
showed one additional cell population with high amounts of FITC-dextran uptake.
Looking at the treated cells at 1 MHz and 2.5 MHz, four distinct cell populations
can be seen. The same no uptake, high uptake, and non-viable cell populations can
be seen, but a fourth population appeared showing moderate uptake of both FITC-
dextran and PI. This was considered viable cells, with uptake of FITC-dextran in
this study.
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Figure 3·6: Represenative FL-1 (FITC-dextran) vs. FL-3 (propodium
iodide) flow cytometry scatter plots from individual control and treated
cell populations. (A-C) are the control cell populations for 1, 2.5, and 5
MHz, respectively. (D-F) are the treated cell population for 1, 2.5, and
5 MHz, respectively. The uptake percentage for each cell population is
reported for the scatter plot. The colormaps used to show cell density
were not normalized between scatter plots.
Quantitative flow cytometry results for cell viability and uptake are shown in
Figure 3·7. Viability increased with increasing frequency. The percent of viable
cells was 44.15% (+/- 14.04), 73.66% (+/- 5.25), and 96.50% (+/- 2.4) for 1, 2.5,
and 5 MHz, respectively. Viability was statistically different between all frequencies.
Contrastingly, the percent of cells with uptake was only statistically different at 1
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MHz. Uptake was highest at 1 MHz, with 89.85% (+/- 1.09) of the viable cells showing
uptake. Uptake at 2.5 MHz and 5 MHz was similar with 64.08% (+/- 3.93) and 68.68%
(+/- 4.86), respectively. Figure 3·8 shows the results for the frequency dependence of
uptake efficiency. The uptake efficiency was 39.45% (+/- 13.73), 46.62% (+/- 3.28),
and 66.81% (+/- 5.46) for 1, 2.5, and 5 MHz respectively. While the uptake efficiency
increased with frequency, 5 MHz was the only statistically different frequency from
the rest. Lastly, Figure 3·9 shows results from the MTT assay. Similar to the flow
cytometry data, viability increased with increasing frequency. The cell viability was
19.5% (+/- 5.55), 66.24% (+/- 5.91), and 90.0% (+/- 2.89) for 1, 2.5, and 5 MHz,
respectively. An important qualitative observation during sonoporation experiments
is that there was no observable bubble activity visible to the eye or foam at the cell
suspension/air interface. Additionally, during the sonoporation exposures at 1 MHz,
at v30 seconds into the exposure a visible precipitate appeared that is most likely
due to cellular aggregation caused by extensive cell fragmentation and lysis.
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Figure 3·7: Cell viability and uptake results for delivery of FITC-
dextran to a cell suspension with phase-shift nanoemulsions using 1,
2.5, and 5 MHz ultrasound.
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Figure 3·8: Uptake efficiency results for delivery of FITC-dextran to
a cell suspension with phase-shift nanoemulsions using 1, 2.5, and 5
MHz ultrasound.
3.5 Discussion
Limited studies have investigated frequency-dependent sonoporation. Forbes et al.
(2011) explored the relationship between the inertial cavitation threshold and sono-
poration at 0.92, 3.2, and 5.6 MHz with lipid shelled UCAs. The study suggested
that stable cavitation (linear and/or nonlinear oscillation of the UCA) was respon-
sible for sonoporation and not inertial cavitation. Another study by Sundaram et
al. (2003) used multiple frequencies over a narrow range (20-100 kHz) and showed
the complete opposite conclusion, that sonoporation is dependent on inertial cav-
itation activity. The study included the development of a theoretical model that
related reversible and irreversible membrane permeablization to the number of in-
ertial cavitation events. An important concept from this study is that nearly every
stage of inertial cavitation, including expansion, collapse, and subsequent shockwaves
may contribute to permeablization. As described in Section 3.2.1, other researchers
have shown a correlation between inertial cavitation activity and sonoporation (Hal-
low et al., 2006; Lai et al., 2006). The results from this study with PSNE are the
first to look at frequency-dependent sonoporation efficiency over a relatively large
frequency range, where the use of PSNE allowed for controlled initiation of inertial
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Figure 3·9: Cell proliferation assay results at 24 hours post-
sonoporation with phase-shift nanoemulsions using 1, 2.5, and 5 MHz
ultrasound. The ultrasound settings for each frequency were fixed at
6.5 MPa peak negative pressure, 5 cycle pulses, 250 Hz pulse repetition
frequency, and a 100 second treatment duration. A colorimetric MTT
assay was performed at 24 hours post treatment to determine the level
of cytotoxicity the ultrasound exposure had on the cell population.
cavitation and subsequent microbubble activity as described in Chapter 2. Instead
of using broadband acoustic emission levels as a metric of inertial cavitation activity,
the PCD signals were analyzed in the time domain for temporal features related to
the inertial cavitation activity.
Figure 3·5 and Table 3.1, illustrate the microbubble dynamics after ADV of PSNE
during sonoporation experiments. As shown in Section 2.4, PSNE immediately un-
dergo inertial cavitation above the ADV pressure threshold for all frequencies tested.
High-speed optical microscopy during the vaporization of submicron droplets has
shown that vaporization occurs during the peak negative cycle of the ultrasound
pulse and the newly created microbubbles can rapidly expand and collapse (Reznik
et al., 2013; Sheeran et al., 2013a). Since vaporization of PSNE requires significantly
higher pressures than what is used with traditional UCAs, the microbubbles are im-
mediately subjected to high tensile stress that leads to inertial cavitation. Instead of
the individual PSNE emissions captured in Chapter 2, the PCD data shows evidence
of combined emissions from numerous collapsing microbubbles. Since the pressures
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used in sonoporation experiments were higher than the reported pressure thresholds
in Table 2.2, it is assumed numerous PSNE are vaporizing throughout the focal vol-
ume of the FUS transducer. While it can be justified based on the evidence presented
in this study that the proposed sonoporation mechanism is inertial cavitation, it is
hard to say which stage of inertial cavitation contributes the most.
Looking at the hypothesized microbubble dynamics after ADV of PSNE in Figure
2·4, we can see the that the PSNE vaporizes and then immediately collapses. After
the first collapse, it undergoes a rapid growth followed by a second collapse from the
maximum radius, followed by additional rebounds and collapses. Assuming that each
spike from the PCD signal is from a collapse, the microbubbles actually undergo iner-
tial collapse multiple times post-ADV. It may be more appropriate to define this sort
of acoustic cavitation as high-energy stable cavitation. The collapses are dominated
by the inertia of the fluid, but the microbubbles are not destroyed or fragmented
during the collapse. Perhaps the influx of water vapor or dissolved gas as described
in Section 2.5 provides a cushioned collapse to allow the microbubble to survive and
undergo the subsequent rebound and collapses. Therefore, there is potential to cause
cell membrane permeabilization during multiple expansions, collapses, and shockwave
emissions.
As discussed in Section 3.2.1, the molecular response of cells to ultrasound is
critically important to the success of sonoporation. Up until now, limited studies have
come close to showing uptake efficiency >50%. In this study with PSNE, the uptake
efficiency depended on the ultrasound frequency as shown in Figure 3·8. FUS at 5
MHz was able to produce an uptake efficiency well above 50% (66.81%). This appears
to be mainly due to the reduced microbubble expansion ratio leading to increased
cell viability. This could have important implications for utilizing sonoporation for
intracellular delivery of macromolecules. However, certain applications could benefit
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from the lower uptake efficiencies at 2.5 and 1 MHz. There was still significant uptake
by the viable cells and therefore applications where cell death is beneficial could take
advantage of this scenario. Examples could include gene and drug therapies where
the ultimate goal is to kill cells.
3.5.1 Limitations
The goal of this Chapter was to specifically highlight the frequency-dependent sono-
poration efficiency with PSNE. Ideally, all parameters would be fixed (i.e. both ex-
perimental and ultrasound) and only the frequency would be changed. While this was
the case for these experiments, it is important to note the differences in the ultrasound
fields between 1, 2.5, and 5 MHz. According to the manufacturer’s specifications, the
acoustic characteristics of each transducer is listed in Table 3.2. The focal width and
depth are inversely related to frequency. Therefore, differences in the focal volume
between the three frequencies could lead to varying exposure volumes (i.e. volume
containing cells that are exposed to cavitation). This could produce skewed results,
especially towards 1 MHz, where the large focal volume and violent cavitation activity
could lyse cells much more rapidly than if its focal volume were more similar to the
5 MHz transducer. The data trends seen in Figures 3·7 and 3·9 seemed to indicate
that a fairly linear relationship between frequency and cell viability and no skewing
towards 1 MHz.
Frequency F-number Focal Width (FWHM) Focal Depth (FWHM)
1 MHz 0.98 1.33 mm 13.5 mm
2.5 MHz 0.98 0.73 mm 7.0 mm
5 MHz 1.06 0.32 mm 3.0 mm
Table 3.2: Acoustic characteristics of the focused ultrasound transduc-
ers used in frequency-dependent sonoporation studies with phase-shift
nanoemulsions.
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3.6 Conclusion
Sonoporation with PSNE is highly dependent of the choice of ultrasound frequency
used for ADV. Cell viability decreased dramatically at lower frequencies, due to the
increased expansion ratio and collapse strength of the microbubbles. This translates
to low sonoporation efficiencies at 1 MHz and 2.5 MHz, while 5 MHz was able to
produce an uptake efficiency >50%. These results provide rationale when choosing
the ultrasound frequency used for PSNE vaporization, which depends on the desired
bioeffect. The following chapter will apply these results for delivery of siRNA to a
cell suspension, where uptake efficiency and cell viability is critically important to
examine siRNA-induced bioeffects.
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Chapter 4
Small Interfering RNA Delivery with
Phase-shift Nanoemulsions
4.1 Scope
This chapter focuses on delivery of a biomolecule of interest, siRNA. As described in
Section 1.3.1, siRNA is unable to cross the cell membrane and requires either chemical
or physical transfection methods. As stated in Section 1.4.1, this chapter was actually
carried out before Chapters 2 and 3. Therefore, the earlier chapters will serve as a
foundation to explain the results seen in this chapter. The study of uptake efficiency
is particularly important since siRNA utilizes cellular machinery in the cytoplasm.
For protein knockdown to occur after siRNA delivery, the cell must be able to survive
the transfection method. An experimental investigation was carried using FUS and
PSNE to deliver green fluorescent protein (GFP) targeted siRNA to cancer cells
(107 cells/mL) stably expressing GFP. Similar to the ultrasound parameters used
in Chapter 3, FUS at 5 MHz was used with ultrasound settings of 6.2 MPa peak
negative pressure, 5 cycle pulses, 250 Hz pulse repetition frequency, and 100 second
exposure duration. The concentration of PSNE was varied from 5 × 106 to 1 × 109
PSNE/mL and a PCD was used to explore the relationship between inertial cavitation
activity, PSNE concentration, and siRNA delivery. Results indicate that efficient
siRNA delivery is possible and delivery is directly related to the PSNE concentration
and inertial cavitation activity.
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4.2 Background
4.2.1 Small Interfering RNA Delivery with Sonoporation
Figure 4·1 is a cartoon representation of typical constructs used for siRNA deliv-
ery. As stated in Section 1.3.1, numerous lipid and polymer based nanoparticles have
been developed for siRNA delivery, along with bioconjugate techniques to improve its
pharmacokinetic properties (Burnett et al., 2011). The numerous biological barriers
presented upon systemic siRNA administration is a major obstacle in development
of a successful delivery technique (Juliano et al., 2009; Dominska and Dykxhoorn,
2010). Nuclease stability, pharmacokinetics, biodistribution, clearance by reticuloen-
dothelial system, endothelial barrier, cellular uptake, and endosomal escape are all
major hurdles that need to be addressed in an ideal delivery system.
Bioconjugate
Liposome
Polyplex
Figure 4·1: Cartoon representation of typical techniques for small
interfering RNA delivery.
While most nanoparticles can serve as excellent carriers that protect and shuttle
siRNA to target tissues. Effective cellular entry and then release into the cytoplasm
is perhaps the foremost bottleneck in utilizing siRNA therapeutics. A recent article
showed that endosomal escape of siRNA happens at low efficiencies (1-2%) with lipid-
based nanoparticle delivery (Gilleron et al., 2013). Therefore, it may be beneficial
to bypass the endosomal pathways and deliver siRNA directly into the cell’s cytosol.
Several techniques exist in theory to overcome this issue, such as fusogenic lipids or
TAT-fusion peptides (Endoh and Ohtsuki, 2009; Tseng et al., 2009), however, toxicity
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and immunogenicity concerns limit their applicability.
Kinoshita et al. (2005) was the first to highlight the possibility of using microbub-
bles and ultrasound to bypass the cellular membrane and deliver siRNA directly
into the cytoplasm. Other researchers have used these promising results to develop
microbubble based siRNA delivery systems using ultrasound (Vandenbroucke et al.,
2008; Negishi et al., 2008; Negishi et al., 2011; Tomizawa et al., 2012; Endo-Takahashi
et al., 2012; Carugo et al., 2015). The following sections will detail experiments to
assess whether sonoporation using PSNE can be used to delivery free siRNA to a cell
suspension with high uptake efficiency.
4.3 Materials and Methods
4.3.1 Experimental Set-up
A 5 MHz spherically focused transducer (SU-108, Sonic Concepts, Bothell, Washing-
ton, USA) was submerged in a 37 ◦C water bath and used to sonicate a cell suspension
containing siRNA and PSNE (Figure 4·2). A 1.5 mL polypropylene microcentrifuge
tube was used to house the cell suspension and was partially submerged in the wa-
ter bath to allow propagation of the ultrasound into the suspension. According to
the manufacturers specifications, the focus of the transducer had a full-width half-
maximum (FWHM) beamwidth of 0.32 mm and FWHM depth of 3 mm as shown in
Table 3.2. The transducer was driven using a 55 dB RF amplifier (Electronics & In-
novation, Rochester, NY, USA) and waveform generator (Agilent Technologies Inc.,
Santa Clara, CA, USA). The peak pressure output of the transducer at the focus
was determined using a calibrated 75 µm needle hydrophone (Precision Acoustics,
Dorchester, Dorset, England) positioned behind the wall of the microcentrifuge tube
to account for attenuation. Pressure measurements were made up to 4 MPa (peak
negative pressure) and then the data was extrapolated out to higher pressures using
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a linear fit of data between 2 MPa and 4 MPa peak negative pressure.
Waveform
Generator and
Amplifier
Cell suspension
37o C water bath
Filter, Preamp,
and Data
Acquisition
5 MHz FUS
2 MHz PCD
Figure 4·2: Experimental set-up for small interfering delivery to a cell
suspension with focused ultrasound and phase-shift nanoemulsions. A
5 MHz specially focused ultrasound transducer was used to sonicate a
cell suspension containing small interfering RNA and phase-shift na-
noemulsions with 5 cycles burst of ultrasound (250 Hz pulse repetition
frequency and 100 second exposure duration). A 2 MHz passive cavi-
tation detector was used to capture acoustic emissions during focused
ultrasound exposures for correlation with small interfering RNA deliv-
ery.
A passive cavitation detection scheme similar to the previous study by Zhang and
Porter (2010) was employed for monitoring ADV of PSNE and inertial cavitation
activity. A 2.25 MHz unfocused transducer (Olympus NDT Inc., Waltham, MA,
USA) aligned perpendicular to the 5-MHz transducer (Figure 1) was used as a PCD,
monitoring for acoustic emissions radiated during PSNE vaporization and inertial
cavitation. The signal from the PCD was routed through a 2 MHz narrowband
filter (FL= 1.6 MHz, FU= 2.2 MHz, Allen Avionics Inc., Mineola, New York, USA),
amplified by 30 dB (Model DHPVA-100, Femto, Berlin, Germany), and digitized
using a 14-bit oscilloscope board (GaGe Corp., Lockport, IN, USA) at a sampling
rate of 50 MS/s. During each exposure at various PSNE concentrations, the PCD was
triggered to acquire data upon every ultrasound pulse resulting in 25,000 individual
traces. The data from all exposures was saved and post-processed using MATLAB
(Mathworks, Natick, MA, USA) to quantify acoustic cavitation activity as shown in
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Figure 4·3. Each trace was gated in the time domain and the root mean squared
(RMS) value was computed. The RMS values were then summated for each exposure
and normalized to the exposure with the highest amount of cavitation activity. The
mean and standard deviations of the normalized values were taken at each PSNE
concentration (n=3) to provide a measure of the amount of cavitation activity for
comparison with siRNA uptake and cell viability.
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Figure 4·3: Example signal from the passive cavitation detector and
conversion to root mean squared values over the treatment duration.
(A) Passive cavitation detector signal above and below the vaporiza-
tion threshold. (B) The root mean squared values for individual passive
cavitation detector signals over the entire treatment duration (100 sec-
onds).
A series of preliminary studies were conducted to identify the acoustic pressure,
pulse length, and pulse repetition frequency to be used in combination with PSNE
for facilitating siRNA delivery to cells. We first identified the pressure threshold for
ADV of PSNE by using a similar method documented by Zhang and Porter (2010)
and is similar to the method detailed in Chapter 2. Briefly, PSNE suspensions were
sonicated with 5 cycle pulses and the peak negative pressure was increased (starting
from 2 MPa) until the amplitude of the PCD trace increased by more than a factor
of ten above baseline. Figure 4·3A illustrates the increased signal amplitude when
above the vaporization threshold (peak negative pressure = 6.2 MPa) as compared to
below. Next, PSNE were suspended with 250,000 human breast cancer cells in 25 µL
of PBS and vaporized with FUS (peak negative pressure = 6.2 MPa) and varying pulse
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length (5, 7, and 9 cycles at a 250 Hz pulse repetition frequency) and pulse repetition
frequency (5 cycle pulse at 250, 500, and 1000 Hz). An MTT cell proliferation assay
(ATCC, Manassas, VA, USA) was used to assess cell viability after treatment and
the pulse length and pulse repetition frequency that were the least lethal were used
in subsequent sonoporation studies.
4.3.2 Small Interfering RNA delivery
Human breast adenocarcinoma cells (MDA-MB-231) were used in tests of fluorescent
siRNA delivery while MDA-MB-231 cells stably expressing GFP were used in tests
of functional siRNA delivery. Dulbecco’s Modification of Eagle’s Medium (DMEM)
(Mediatech Inc., Manassas, VA, USA) was used as the culture medium and was sup-
plemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals Inc., Flowery
Branch, GA, USA), 2% L-glutamine (200 mM stock) (Mediatech Inc., Manassas, VA,
USA), and 1% penicillin streptomycin (5 mg/mL stock) (Mediatech Inc., Manassas,
VA, USA). Prior to ultrasound experiments, cells were grown to confluence in 75
cm2 tissue cultured flasks and harvested using trypsin-EDTA (0.25% stock) (Mediat-
ech Inc., Manassas, VA, USA). Cells were counted using a hemacytometer (Hausser
Scientific, Horsham, PA, USA) and resuspended in FBS free growth media at a con-
centration of 2.5×107 cells/mL. Aliquots of 10 µL were added to 1.5 mL polypropylene
microcentrifuge tubes and placed in a 37 ◦C water bath until the treatment.
Fluorescently tagged siRNA (siGLO green, GE Dharmacon, Lafayette, CO, USA)
was suspended in PBS at a molar concentration of 50 µM. For each treatment, the
cell suspension was mixed with 5 µL of siGLO and 10 µL of a stock PSNE solution
to give a final volume of 25 µL, with a molar concentration of 10 µM siGLO and
PSNE concentrations of 5× 106, 1× 107, 2.5× 107, 5× 107, 1× 108, 2.5× 108, 5×
108, or1×109 PSNE/mL. The focus of the 5 MHz transducer was positioned inside the
cell suspension using a three-axis translation stage system (ThorLabs Inc., Newton,
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New Jersey, USA) and the suspension was immediately exposed to ultrasound (5
cycle pulses, 6.2 MPa peak negative pressure, 250 Hz pulse repetition frequency, 100
second exposure) with a total of three exposures at each PSNE concentration.
Knockdown experiments were performed using similar experimental parameters
except GFP targeted siRNA (GFP duplex I, GE Dharmacon, Lafayette, CO, USA)
was used at molar concentrations of 0.1, 1.0, and 10 µM. PSNE were fixed at a
concentration of 1 × 109 PSNE/mL and cells at a concentration of 107 cells/mL.
Control groups using no siRNA (blank PBS) and non-targeting siRNA (siGENOME
Non-targeting siRNA 2, GE Dharmacon, Lafayette, CO, USA) were also exposed to
ultrasound. After the ultrasound exposures, cells were washed and incubated in 25
cm2 tissue culture flasks for 48 hours before analysis of GFP knockdown. Knockdown
experiments were also performed with a commercially available transfection agent
(DharmaFECT 4, GE Dharmacon, Lafayette, CO, USA) according to the company’s
protocol. Briefly, cells were seeded onto 12 well plates at 50,000 cells per well and
allowed to adhere overnight. Transfections were performed the following day using
GFP targeted and non-targeted siRNA at molar concentrations of 50 nM (1 mL total
volume in each well). The growth media was replaced after 24 hours and cells were
harvested for analysis at 48 hours.
4.3.3 Analysis
For evaluation of ultrasound-mediated delivery of fluorescently tagged siRNA, cells
were washed and resuspended in 250 µL of cold PBS (106 cells/mL) within 30 minutes
of the ultrasound exposure. Propidium iodide (PI) was added at a concentration of
4 µg/mL to stain cells that had irreparable damage to the cell membrane during
ultrasound exposure and therefore were defined as non-viable. The fraction of cells
with intracellular siRNA and/or stained with propidium iodide were quantified using
flow cytometry (FACS Calibur, BD Biosciences, San Jose, CA, USA). Assuming the
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flow cytometer operates at a constant flow rate, data was collected for one minute
for comparison of the total number of cells counted between control and treatment
groups to assure that no significant cell fragmentation or lysis had occurred during
the treatment. Viable cells showing uptake were gated on the FL1 (siRNA) vs.
FL3 (PI) scatter plot to eliminate non-viable cells during analysis of siRNA delivery.
Uptake was defined as the percentage of cells above a certain threshold fluorescent
intensity. The mean percentage of cells above the threshold for the control group was
subtracted from each individual treatment at varying PSNE concentrations. Viability
was defined in a similar manner using PI fluorescence, by subtracting the mean value
of the control group from each individual treatment at varying PSNE concentrations.
Qualitative analysis of siRNA uptake was performed by plating treated cells on 35
mm glass bottom dishes (MatTek Corporation, Ashland, MA, USA) for imaging with
fluorescent microscopy (IX81, Olympus America Inc., Melville, NY, USA) eight hours
after ultrasound exposure.
Cells treated with GFP targeted siRNA were harvested at 48 hours for analysis
with flow cytometry. GFP knockdown was quantified by comparing the mean fluores-
cent intensity of the entire treated cell populations to that of the control populations,
which was defined as a percent reduction in GFP fluorescent intensity. A second
metric of cell viability was performed after delivery of GFP targeted siRNA using a
cell proliferation assay (MTT Cell Proliferation Assay, ATCC, Manassas, VA, USA).
The assay was used to quantify and compare cell proliferation between treated and
control cell populations. Given that cell proliferation requires viable and functional
cells, this assay captures the acute and chronic effects of acoustic cavitation on cell
viability.
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4.4 Results
4.4.1 Fluorescent Small Interfering RNA Delivery
The dependence of cell viability on pulse length and pulse repetition frequency is
shown in Figure 4·4. Varying pulse lengths (5, 7, and 9 cycles) at a fixed pulse
repetition frequency (250 Hz) and varying pulse repetition frequencies (250, 500, and
1000 Hz) at a fixed number of cycles (5 cycles) were used to explore the relationship.
An overall decrease in cell viability can be seen with increasing pulse lengths and pulse
repetition frequencies. Statistically significant differences relative to the ultrasound
parameters used for siRNA delivery (5 cycles, 250 Hz PRF) can be seen at the highest
pulse lengths and pulse repetition frequencies.
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Figure 4·4: Results from the cell proliferation assay exploring the de-
pendence of pulse length and pulse repetition frequency on cell viability.
Focused ultrasound at 5 MHz was used at a peak negative pressure of
6.2 MPa for 100 seconds.
The use of a fluorescently tagged siRNA allowed assessment of siRNA uptake
with flow cytometry and fluorescent microscopy. Figure 4·5 displays representative
fluorescent microscopy and flow cytometry results. A large majority of the cells show
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uptake of siRNA, which was tagged with a green fluorophore. This specific siRNA
molecule was designed to avoid RNAi machinery and localize to the nucleus over 24
hours. After eight hours a large majority of the siRNA appears to be diffuse in the
cytosol of the cells and not localized to endosomes or cell nuclei.
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Figure 4·5: Representative fluorescent microscopy and flow cytome-
try results from fluorescent small interfering RNA delivery experiments
with phase-shift nanoemulsions. (A) Brightfield and (B) fluorescent
images of cells eight hours post ultrasound exposure. Flow cytometer
results of siRNA uptake at (C) 1 × 109, (D) 1 × 108, and (E) 1 × 107
PSNE/mL are shown in the bottom three histograms. Cells showing
uptake of siRNA were gated using the FL1 (green) fluorescent intensity
channel of the flow cytometer.
Representative histograms of the flow cytometer results at different PSNE con-
centrations (1×109, 1×108, and 1×107 PSNE/mL) are also shown in Figure 4·5C-E.
Two distinct cell populations emerged after ultrasound exposure showing high uptake
or no uptake at all. There also exists some heterogeneity in uptake, with subpop-
ulations of cells outside and in between the two distinct cell populations. This is
70
consistent with previous sonoporation studies, which showed a similar heterogeneity
in regards to uptake (Guzma´n et al., 2001; Sundaram et al., 2003). Three runs at
different PSNE concentrations were performed and the quantitative results of siRNA
uptake and cell viability are shown in Figure 4·6. The percent of cells with siRNA
uptake and percent of viable cells both had logarithmic trends that plateaued with
increasing amounts of PSNE. There was no significant difference between treated and
control groups in terms of the total number of cells counted by the flow cytometer.
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Figure 4·6: The effect of phase-shift nanoemulsion concentration on
cellular uptake and viability during the delivery of fluorescent small
interfering RNA.
Passive cavitation detection during the ultrasound treatments revealed a strong
dependence on PSNE concentration with the amplitude and duration of cavitation
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activity. Figure 4·7A-D shows representative plots of the RMS amplitude of the PCD
signal versus exposure duration at various PSNE concentrations (1 × 109, 1 × 108,
1 × 107 PSNE/mL, and no PSNE). The percentage of cells with siRNA uptake was
correlated with the relative amount of cavitation activity as shown in Figure 4·8.
The mean amount of cavitation activity was plotted against the mean uptake for
each treatment group. Uptake and cavitation activity both had logarithmic trends
that plateaued with increasing concentrations of PSNE (Figures 4·7E and 4·6). A
linear relationship between cavitation activity and uptake was seen in Figure 4·8,
with no significant changes in uptake at the highest levels of cavitation activity. The
percentage of viable cells on the other hand had a weak correlation with cavitation
activity as shown in Figure 4·8. A slight decrease in cell viability can be seen with
increasing amounts of cavitation activity.
4.4.2 Functional Small Interfering RNA Delivery
Functional siRNA experiments were performed with siRNA designed to knockdown
GFP. The flow cytometer histograms in Figure 4·9A-B show an overall shift to the
left for treated cells, indicating a reduction in the amount of GFP produced by cells
that survived the ultrasound exposure. Only a fraction of the cells showed a reduction
in GFP with treatments using PSNE (Figure 4·9A), while the entire cell population
showed a decrease with the commercial transfection agent (Figure 4·9B). This may
be explained by the distinct populations of cells showing uptake or no uptake as
observed with fluorescent siRNA delivery (Figure 4·5), therefore leading to hetero-
geneity in GFP reduction. The bar plots in Figure 4·9C show the percent reduction
in GFP fluorescent intensity for respective treatment and control groups. The highest
concentration of GFP siRNA resulted in an almost 50% reduction in GFP intensity,
which was comparable to knockdown achieved with siRNA delivered via a commercial
transfection agent (54 +/- 0.7% reduction).
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Figure 4·7: The dependence of phase-shift nanoemulsion concentra-
tion on cavitation activity during small interfering RNA delivery exper-
iments. (A-D) are example root mean squared values over the exposure
duration at (A) 1 × 109, (B) 1 × 108, and 1 × 107 PSNE/mL. (E) is a
plot of the mean normalized cavitation activity value versus phase-shift
nanoemulsion concentration.
4.5 Discussion
As discussed in Section 4.2.1, the strategies for siRNA delivery are largely based upon
nanoparticle carriers that suffer from toxicity issues, poor uptake by desired cells,
and inefficient endosomal escape and release of siRNA to the target area (Wu et al.,
2014). PSNE in combination with FUS technologies may provide a way to localize and
control the release and delivery of siRNA therapeutics. Sonoporation has previously
been offered as an option for in vitro siRNA delivery (Kinoshita and Hynynen, 2005).
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Figure 4·8: The correlation of cavitation activity with cellular uptake
and viability during small interfering RNA delivery with phase-shift
nanoemulsions.
Unfortunately, as described in Section 3.2.1, sonoporation has shown limited efficiency
for intracellular delivery of a broad spectrum of biomolecules (Liu et al., 2012). The
current study was motivated by the need to resolve this limitation in order to enable
development of an alternative delivery method for siRNA therapeutics.
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Figure 4·9: Comparison of green fluorescent protein reduction after
delivery of green fluorescent protein targeted small interfering RNA
using phase-shift nanoemulsions or a commercial transfection agent.
Flow cytometry data for control and treated cell populations 48 hours
post green fluorescent protein targeted small interfering RNA delivery
using (A) PSNE and sonoporation or (B) a commercial transfection
agent. (C) Bar plots showing the overall reduction of green fluorescent
protein intensity at various concentrations of green fluorescent protein
targeted small interfering RNA (10 µM, 1 µM, and 0.1 µM) and controls
(commercial transfection agent, negative siRNA, and no siRNA).
Reiterating from previous sections, sonoporation is made possible by acoustic
cavitation. Expanding and compressing/collapsing microbubbles near cells can cause
stresses that act to disrupt cell membranes temporarily or permanently, resulting in
either viable or non-viable sonoporated cells, respectively. The microbubble activity
can be violent or gentle depending on the type of cavitation. Stable cavitation is de-
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fined by repetitive oscillations around some equilibrium size, while inertial cavitation
is defined by explosive growth and collapse of microbubbles (Neppiras, 1980; Leighton,
1994). High-speed optical microscopy during the vaporization of submicron droplets
has shown that vaporization occurs during the peak negative cycle of the ultrasound
pulse and the newly created microbubbles rapidly expand and collapse (Reznik et al.,
2013; Sheeran et al., 2013a). Since vaporization of PSNE requires significantly higher
pressures than what is used with traditional UCAs, the microbubbles are immediately
subjected to high tensile stress that could lead to inertial cavitation. The short, high
pressure pulses used in this study along with the detection of broadband emissions
supports the theory of inertial cavitation as the main source of sonoporation.
Several studies have shown that inertial cavitation can permeable cells, but often
kills a large fraction of cells in the process (Sundaram et al., 2003; Hallow et al.,
2006; Lai et al., 2006; Forbes et al., 2008). Acoustic cavitation induced cell lysis has
a strong correlation with pulse length (Everbach et al., 1997; Brayman and Miller,
1999; Chen et al., 2003b), which suggests that short pulses (<10 cycles) may be more
ideal for achieving reversible sonoporation. Sheeran et al. (2013a) showed that vapor-
ized nanoemulsions are strongly affected by subsequent cycles after vaporization and
undergo large amplitude oscillations and collapse that could cause extensive damage
to cells. As shown in Figure 4·4, the viability of cells subjected to PSNE nucleated
acoustic cavitation was indeed inversely related to pulse length. Based upon this find-
ing, the shortest pulse length (i.e. 5 cycles) that ensured PSNE vaporization while
minimizing cell death was selected for studies on siRNA delivery.
It has been suggested that the ratio between cavitation nuclei and cell concen-
tration may be a critical factor in sonoporation (Guzma´n et al., 2003). Ward et al.
(2000) hypothesized that increasing this ratio would reduce the bubble-to-cell distance
significantly, thus increasing the likelihood of acoustic cavitation-induced membrane
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disruption. Additionally, studies using ultrasound contrast agents as cavitation nu-
clei have shown that quantified inertial cavitation activity is directly proportional
to UCA concentration (Chen et al., 2003a; Hallow et al., 2006; Lai et al., 2006).
We quantified inertial cavitation activity nucleated from PSNE and determined it
had a logarithmic relationship with PSNE concentration (Figure 4·7E). This increase
in inertial cavitation activity was accompanied by an increase in siRNA uptake by
suspended cells (Figure 4·8). The fraction of suspended cells to which siRNA was
delivered was directly proportional to the concentration of PSNE and therefore the
PSNE:cell ratio. Ratios ranged from 0.5 to 100, with significant (>50%) uptake at
PSNE:cell ratios of 25, 50, and 100. This finding is in good agreement with published
results that show a similar relationship between sonoporation and UCA concentra-
tion (Miller and Quddus, 2000; Lai et al., 2006; Karshafian et al., 2010). Unlike these
published studies the cell viability was dramatically improved, remaining above 90%
when measured via propidium iodide staining immediately following sonication. We
speculate that the high cell viability coupled with relatively efficient siRNA delivery
(i.e. >50% of initial cell population) was due to the use of very short pulses, which we
showed previously was most ideal for minimizing cell death (Figure 4·4). Published
sonoporation studies predominately have used pulse lengths longer than ten cycles,
which unfortunately killed more cells (Lai et al., 2006; Karshafian et al., 2009). Cell
viability differed depending on the metric used for quantification. Propidium iodide
staining showed limited cell death immediately following treatment, while the cell
proliferation assay showed a further reduction in viability measured at 24 hours af-
ter ultrasound exposure (Figure 4·4). We believe the proliferation assay takes into
account all modes of cell death (irreparable cell membrane damage, apoptosis, cell
fragmentation, etc.) and is more sensitive to how well the cells recover after the
treatment.
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In addition to the concentration of cavitation nuclei, we hypothesized that sono-
poration efficiency depended strongly upon the duration of inertial cavitation activity.
Studies have reported that inertial cavitation activity nucleated by UCAs disappeared
within the first few seconds of ultrasound exposure (Hallow et al., 2006; Lai et al.,
2006). This activity has also been reported in hemolysis experiments with UCAs, in
which the authors describe a cascade effect of total microbubble destruction (Chen
et al., 2003b). In our study, inertial cavitation nucleated by PSNE was sustained
throughout the ultrasound exposure (Figure 4·7), thus increasing the probability of
acoustic cavitation-induced cell membrane permeation and the resultant sonoporation
efficiency. The sustained activity of PSNE may be explained by the higher concentra-
tions of PSNE (109 vs. 107 per mL for UCAs) used in this study compared to previous
sonoporation experiments. Since PSNE have a liquid core, high concentrations can
be used without the acoustic shielding effects associated with high concentrations
of gas-filled UCAs. These high concentrations in combination with the small focal
volume used in this study may leave unvaporized PSNE outside the focal that can
eventual propagate through and sustain cavitation activity.
PSNE can be fabricated to have mean diameters that are small enough to take
advantage of the EPR effect and accumulate in solid tumors (Rapoport et al., 2009b;
Kopechek et al., 2013; Williams et al., 2013). While studies have shown inconsis-
tencies with the EPR effect due to tumor heterogeneity, it is still a valuable way of
targeting solid tumors with nanoparticles (Bae and Park, 2011). Although free siRNA
was used in this study, the functionality of a lipid shell allows addition of cationic
or functional lipids that could be used to anchor the siRNA to the PSNE surface
through electrostatic or covalent interactions. Previous ultrasound based siRNA de-
livery systems have used cholesterol-modified siRNA or cationic bubbles to complex
the siRNA to the surface (Negishi et al., 2008; Endo-Takahashi et al., 2012). It is
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unknown whether the high PSNE:cell ratios and extracellular siRNA concentrations
used in this in vitro study can be translated to in vivo scenarios and will be the goal
of future studies.
Relationship to Previous Chapters
The short pulses and sustained inertial cavitation can begin to explain the high siRNA
uptake and viability seen in this study. Looking back at Chapter 3, we can see that
the ultrasound frequency used in this study was the key to high viability. FUS at 5
MHz just so happened to be a sweet spot, where frequencies <5 MHz caused more
cell death. This was explained by the reduced expansion ratio of the microbubbles
after ADV of PSNE at 5 MHz, which led to less violent collapses.
4.5.1 Limitations
The sample volume relative to the transducer focal volume can have dramatic effects
on acoustic cavitation-induced permeabilization of cell membranes. Assuming an el-
lipsoidal focal volume for the transducer used in this study, less than 1% of the total
cell suspension volume lied within in the FWHM volume of the focus. The effect of
this limited exposure volume can most clearly been seen in the heterogeneity of siRNA
delivery, with subpopulations of cells showing uptake and no uptake. It is hypothe-
sized that this effect is do to a large majority of the cell population not experiencing
the same levels of acoustic cavitation induced stress. Some cells may never migrate
through the focal volume of the transducer to interact with the microbubbles and
others may experience different levels of permeation. The results from GFP siRNA
delivery showed similar effects of heterogeneous delivery. A subpopulation of cells
showed reduced levels of GFP indicated by their reduction in fluorescent intensity.
This heterogeneity could be alleviated in future studies by mechanically translating
the focus throughout the cell suspension or by actively mixing the suspension during
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treatment.
4.6 Conclusion
Successful delivery of free siRNA to cancer cells with PSNE was achieved in vitro
and was directly related to acoustic cavitation emissions. Our results indicate that
with increasing PSNE-to-cell ratios, the amount of siRNA uptake and relative cavi-
tation levels increased. This highlights the importance of bubble to cell interactions
when invoking desired or undesired bioeffects caused by acoustic cavitation. PSNE
displayed sustained acoustic cavitation levels throughout exposure durations and is
unique compared to traditional UCAs. The ability to sustain acoustic cavitation ac-
tivity could have a profound impact on other cavitation related therapies. In regards
to PSNE as siRNA delivery vehicles, the amount of GFP knockdown in this study
was similar to a commercial transfection agent. Due to the limitations of the ultra-
sound set-up, heterogeneous knockdown was seen throughout the cell population and
resulted in slightly lower levels of knockdown.
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Chapter 5
Conclusion
5.1 Summary
The results presented in this body of work emphasize the unique properties of PSNE.
These nanoparticles possess the ideal physiochemical properties that could allow them
to circulate for hours in the bloodstream, extravasate into tissue, and reach areas of
the body otherwise thought inaccessible to acoustic cavitation related bioeffects. This
is a major advance over micron sized UCAs, which are rapidly cleared from circulation
and limited to the vascular space. The goal of this project was to combine the above
properties of PSNE with their ability to serve as acoustic cavitation nuclei, in an
aim to create an efficient siRNA delivery system. The scope of this thesis deals with
initial proof of concept in vitro studies on whether sonoporation with PSNE can
deliver siRNA to a cell suspension efficiently.
Chapter 2 aimed to understand the microbubble dynamics of PSNE after ADV.
While numerous high speed imaging studies have uncovered the dynamics of micron
and submicron PFC droplets, there is still a limited understanding of how the mi-
crobubbles respond to the remainder of the ultrasound pulse after ADV. Therefore,
an experimental set-up was designed to capture acoustic emissions from the newly
formed microbubbles after ADV and attempt to use this information to uncover the
microbubble dynamics. First, the threshold ultrasound pressure for ADV of PSNE
was determined using FUS at 1, 2.5, and 5 MHz. The peak negative pressure thresh-
old was in the 4-6 MPa range and did not show a correlation with the ultrasound
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frequency. Using a broadband PCD to look at acoustic emissions near the pressure
threshold, the time and frequency information of individual PSNE undergoing ADV
could be analyzed. Example PCD signal and hypothesized microbubble dynamics are
shown in Figure 2·4. The existence of post-excitation voltage spikes in the PCD signal
led to the understanding that microbubbles undergo inertial cavitation at the ADV
threshold. Since the microbubbles scatter the remainder of ultrasound pulse after
ADV, the time between this scattered signal and collapse spikes could be analyzed to
predict the maximum size of the microbubble with the Raleigh collapse model. It was
shown that the maximum size obtained by the microbubble after ADV was related
to the ultrasound frequency and increased with decreasing frequencies.
These results were explained by the differences in the ultrasound period. Lower
frequencies allow microbubbles more time to grow and gain momentum during the
rarefactional period of the ultrasound pulse. This led to an increase in maximum
radius at lower frequencies. It was reasoned that the increase in the maximum radius
led to a corresponding increase in the bubble collapse intensity. Thus, it was hypoth-
esized that control over acoustic cavitation related bioeffects could be obtained with
the choice of frequency. Chapter 3 explored this hypothesis by testing the frequency-
dependent sonoporation efficiency with PSNE. By fixing all experimental parameters
except frequency, the effects of varying microbubble expansion ratios on a cell suspen-
sion during sonoporation could be explored using FUS at 1, 2.5, and 5 MHz. Results
demonstrated that cell viability is highly dependent on the ultrasound frequency and
therefore the expansion ratio. FUS at 1 MHz caused extensive cell death and literally
seemed to obliterate the cell suspension due to significant cell lysing. The uptake ef-
ficiency (number of viable cells with uptake divided by the number of cells originally
in the sample) decreased with lower frequencies. FUS at 5 MHz showed the highest
efficiency (66.8%) and is a significant breakthrough in the field of therapeutic ultra-
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sound. As reviewed by Liu et al. (2012), efficient uptake (>50%) with sonoporation
has never been reported in literature.
Finally, the above results from Chapters 2 and 3 were used to explain previous
findings in Chapter 4, showing that siRNA delivery with PSNE and sonporation was
possible with high efficiencies. In these in vitro studies, FUS at 5 MHz was used to
deliver siRNA to cells using acoustic cavitation activity derived from PSNE. Based
on the frequency-dependent uptake efficiencies seen in Chapter 3, the high viability
was attributed to the limited expansion ratios and subtle collapse of microbubbles
due to activation at 5 MHz. Another important aspect of this study was the PSNE
concentration dependence on siRNA uptake and cavitation activity. The PSNE con-
centration correlated with siRNA uptake and inertial cavitation levels. These results
highlighted the importance of the PSNE:cell ratio in getting enough cavitation ac-
tivity to cause significant uptake. Additionally, at high PSNE concentrations, PSNE
displayed sustained inertial cavitation levels throughout the exposure durations. This
sort of sustained activity is not observed with other types of acoustic cavitation nu-
clei, which are typically depleted within seconds of FUS exposure. Taking advantage
of the sustained cavitation activity could have a profound impact on other cavitation
related therapies.
5.2 Future Directions
PSNE could serve as a platform for numerous additional therapeutic ultrasound ap-
plications that utilize the mechanical effects of acoustic cavitation. In line with the
goals of this project, the PSNE formulation could be adjusted to incorporate siRNA
into the phopholipid shell. Therefore, PSNE could serve as a nanoparticle carrier for
siRNA that could bind and protect siRNA in circulation and then facilitate delivery
upon ADV. Figure 5·1 is a cartoon representation of a PSNE and how siRNA could
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be possibly incorporated into the shell. Functional groups can be put on the end
of the siRNA molecule for covalent attachment to phospholipids in the shell using
bioconjugate chemistry. Researchers have shown that cholesterol conjugated siRNA
can be incorporated into ultrasound responsive echogenic liposomes (Negishi et al.,
2011). Additionally, others have shown that siRNA can be conjugated to phospho-
lipds and other molecules for unique nanoparticle carriers (Musacchio et al., 2010;
Navarro et al., 2011). Future experiments would need to first assess whether the
siRNA is actually protected in physiological environments against enzymatic degra-
dation. Next, similar sonoporation experiments carried out in Chapter 4 would need
to be performed with the siRNA bound to the PSNE shell. It is unknown whether
siRNA can be released upon ADV of PSNE for uptake into cells. Promising results
from these studies could transition into initial in vivo studies.
Liquid 
Perfluorocarbon
Core
Phospholipid
Polyethylene glycol (PEG)
GCAAAGCUGACCCUGAAGUUCAU
CGCGUUUCGACUGGGACUUCAAG
GCAAAGCUGACCCUGAAGUUCAU
CGCGUUUCGACUGGGACUUCAAG
siRNA
Figure 5·1: Cartoon representation of a phase-shift nanoemulsion with
small interfering RNA bound to the phopholipid shell.
Further analysis of the frequency dependence of ADV of PSNE could provide ad-
ditional control of the microbubble dynamics following ADV of PSNE. ADV with
FUS frequencies greater than 5 MHz could allow for ADV of PSNE without inertial
cavitation. Hypothetically, there should be transition as the frequency is increased
where the microbubbles no longer undergo inertial cavitation, due to the shortening
of the ultrasound period over which they have to expand. This sort of scenario could
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be utilized for a different type of intracellular delivery technique, where PSNE are
first taken up by cells through endosomal pathways and then ADV of PSNE could
be initiated. This sort of intracellular sonoporation technique could be more effica-
cious than traditional sonoporation techniques where the microbubbles are located
outside of the cell. Localizing the cell and PSNE together could insure that the mi-
crobubbles are close enough to the cell membrane to cause permeabilization. The sort
of controlled cavitation formation inside of a cell could also be used for endosomal
release of drugs, where the expansion of the microbubble after ADV could disrupt
the endosomal vesicle. The importance of a non-energetic cavitation event will be
very important, as a energetic microbubble collapse inside the cell could cause exten-
sive damage. Lastly, this approach could be used for permeabilization of the nuclear
envelope, which is a major barrier for successful DNA delivery. This could allow ex-
ogenous genetic material access to the nucleus for improvement of incorporation into
the genome.
Turning away from in vivo applications, optimization of sonoporation with PSNE
could be a useful in vitro tool for introducing foreign material into cells. Besides
siRNA, CRISPR-based technologies have emerged as a promising tool to modify
gene expression (Boettcher and McManus, 2015). Current methods have limitations,
mainly in regards to their toxicity and off target effects. An efficient, mechanical
based way for intracellular delivery of large macromolecules could potentially enable
numerous research and clinical applications. Researchers are looking to to intro-
duce foreign material into difficult to transfect stem and immune cells for molecular
reprogramming. Sonoporation with PSNE could be a powerful technique for this ap-
plication. The limitations of the current experimental set-up, such as the fixed FUS
focal volume and incomplete exposure of all cells to cavitation, could be addressed to
create a acoustic cavitation based device for introducing foreign material into cells.
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